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MECHANISMS REGULATING THE P120-CATENIN/KAISO PATHWAY

Publication No._______________
Ji Yeon Hong, Ph.D.
Supervisory Professor: Pierre D. McCrea, Ph.D.

The Wnt pathways contribute to many processes in cancer and developmental
biology, with β-catenin being a key canonical component. P120-catenin, which is
structurally similar to β-catenin, regulates the expression of certain Wnt target
genes, relieving repression conferred by the POZ/ zinc-finger transcription factor
Kaiso. In my first project, employing Xenopus embryos and mammalian cell lines, I
found that the degradation machinery of the canonical Wnt pathway modulates
p120-catenin protein stability, especially p120 isoform-1, through mechanisms
shared with β-catenin. Exogenous expression of destruction-complex components
such as GSK3β or Axin promotes p120-catenin degradation, and consequently, is
able to rescue developmental phenotypes resulting from p120 over-expression
during early Xenopus embryonic development. Conversely, as predicted, the in vivo
depletion of either Axin or GSK3β coordinately increased p120 and β-catenin levels,
while p120 levels decreased upon LRP5/6 depletion, which are positive modulators
in the canonical Wnt pathway. At the primary sequence level, I resolved conserved
GSK3β phosphorylation sites in p120’s (isoform 1) amino-terminal region. Pointmutagenesis of these residues inhibited the association of destruction complex
proteins including those involved in ubiquitination, resulting in p120-catenin
vii	
  
	
  

stabilization. Importantly, we found that two additional p120-catenin family
members, ARVCF-catenin and δ-catenin, in common with β-catenin and p120,
associate with Axin, and are degraded in Axin’s presence. Thus, by similar means,
it appears that canonical Wnt signals coordinately modulate multiple catenin
proteins having roles in development and conceivably disease states.

In my second project, I found that the Dyrk1A kinase exhibits a positive effect
upon p120-catenin levels. That is, unlike the negative regulator GSK3β kinase, a
candidate screen revealed that Dyrk1A kinase enhances p120-catenin protein
levels via increased half-life. Dyrk1A is encoded by a gene located within the
trisomy of chromosome 21, which contributes to mental retardation in Down
Syndrome patients. I found that Dyrk1A expression results in increased p120
protein levels, and that Dyrk1A specifically associates with p120 as opposed to
other p120-catenin family members or β-catenin. Consistently, Dyrk1A depletion in
mammalian cell lines and Xenopus embryos decreased p120-catenin levels. I
further confirmed that Dyrk overexpression and knock-down modulates both
Siamois and Wnt11 gene expression in the expected manner based upon the
resulting latered levels of p120-catenin. I determined that Dyrk expression rescues
Kaiso depletion effects (gastrulation failure; increased endogenous Wnt11
expression), and vice versa. I then identified a putative Dyrk phosphorylation region
within the N-terminus of p120-catenin, which may also be responsible for Dyrk1A
association. I went on to make a phosphomimic mutant, which when overexpressed, had the predicted enhanced capacity to positively modulate endogenous
viii	
  
	
  

Wnt11 and Siamois expression, and thereby generate gastrulation defects. Given
that Dyrk1A modulates Siamois expression through stabilization of p120-catenin, I
further observed that ectopic expression of Dyrk can positively influence β-catenin’s
capacity to generate ectopic dorsal axes when ventrally expressed in early Xenopus
embryos. Future work will investigate how Dyrk1A modulates the Wnt signaling
pathway through p120-catenin, and possibly begin to address how dysfunction of
Dyrk1A with respect to p120-catenin might relate to aspects of Down syndrome. In
summary, the second phase of my graduate work appears to have revealed a novel
aspect of Dyrk1A/p120-catenin action in embryonic development, with a functional
linkage to canonical Wnt signaling. What I have identified as a “Dyrk1A/p120catenin/Kaiso pathway” may conceivably assist in our larger understanding of the
impact of Dyrk1A dosage imbalance in Down syndrome.
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Chapter I

Introduction and Background

Wnt signaling pathways

Wnt signaling pathways are involved in multiple aspects of development and
tumorigenesis (1-5). The Wnt family of ligands possesses at least 19 members,
shown to be present in human and mice. Each of the Wnt ligands has unique
expression patterns, some overlapping, and distinct functions during development.
The Wnt pathways are roughly categorized into the canonical, and non-canonical
pathway. Both are initiated by the binding of Wnt ligands to Frizzled receptors. In
what is defined as canonical Wnt signaling, β-catenin is a key element transmitting
Wnt signals into the nucleus via high mobility group (HMG) box transcriptional
repressor LEF/TCF, to activate multiple Wnt target genes (1, 6, 7). Non-canonical
Wnt signals are defined as other than that of the β-catenin-mediated pathway. Noncanonical Wnt pathways are mediated through Rho GTPases, Ca2+/PKC or JNK
(Figure 1). Recent evidence indicates that non-canonical Wnt signals antagonize
canonical Wnt pathways in certain contexts, although the precise mechanisms are
still under study (8, 9). Mutations in Wnt pathway components result in varied
developmental defects and human diseases including cancer.

1

Figure 1. A schematic diagram of selected components of the canonical and
non-canonical Wnt pathway. Wnt ligands bind to the Frizzled receptor and
LRP5/6 co-receptor, which recruits Dishevelled (Dvl). Upon activation of Dvl, Axin
and GSK3β are recruited to the plasma membrane, leading to β-catenin’s
stabilization and accumulation in the cytoplasm. Increased levels of β-catenin enter
the nucleus to activate multiple Wnt target genes. The non-canonical Wnt pathways
include the PCP and Calcium pathways, amongst others. Upon the binding of Wnt
ligands to Frizzled receptors, activated Dvl signals through small GTPases and/ or
C-Jun N-terminal kinase (JNK). Calcium signaling is mediated in part via
Phospholipase-C (PLC), leading to calcium release and Cam Kinase II (CamKII)
activation.

2

3

The regulation of β-catenin’s stability in canonical Wnt signaling

The metabolic stability of β-catenin is regulated by destruction complex
components including GSK3β (Glycogen Synthase Kinase-3β), CK1α (Caseine
Kinase-1α), Axin and APC (Adenomatus polyposis coli) (10-14). In the absence of
Wnt signals, β-catenin is targeted for phosphorylation by CK1α and GSK3β in
association with a larger scaffolding complex including Axin and APC. β-catenin is
then ubiquitinated via β-TrCP (β-transducin repeat-containing protein), a substrate
recognition / E3 subunit of ubiquitin ligase, resulting in β-catenin’s degradation
through the ubiquitin-mediated proteasome pathway (15-17). On the other hand,
when extracellular Wnt ligands bind to the transmembrane receptor:coreceptor
complex of Fz (Frizzled) and LRP (Low density lipoprotein receptor-Related
Protein), intracellular Dvl (Dishevelled) becomes activated by unknown mechanisms
(18-21). Among other possibilities, activated Dsh together with LRP is thought to
sequester Axin and GSK3β to the inner plasma membrane and inhibit GSK3β’s
ability to phophorylate β-catenin, thereby promoting β-catenin stabilization (18, 19,
22-28). This pool of β-catenin responds to additional signals before accessing the
nucleoplasmic space (29), where β-catenin relieves repression otherwise conferred
by the HMG (High Mobility Group) proteins LEF (Leukocyte Enhancing Factor) or
TCF (29-32) (Figure 1). Genes activated by the β-catenin/LEF/TCF complex
(canonical-Wnt target genes) are numerous, with well-known examples including
Siamois (Xenopus), as well as c-Myc and Cyclin-D1 (33-36). In addition to the Wnt
4

pathway’s extensive engagement in embryogenesis and adult-tissue homeostasis,
pathological pathway activation is linked to multiple human diseases such as those
characterized by bone abnormalities and cancer (37, 38).

P120-catenin subfamily members

Members of the p120-catenin subfamily include p120-catenin, ARVCF-catenin,
δ-catenin, p0071, and plakophilin (39, 40) (Figure 2). The p120 subfamily members
bear limited structural resemblance to the β-catenin subfamily members, β-catenin
and plakoglobin (γ-catenin). The most obvious similarity is that each contains a
central Arm (Armadillo) domain comprised of either 9 (p120 and plakophilin
subfamily members) (41) or 12 (β-catenin & plakoglobin/ γ-catenin) Arm repeats.
Through such Arm domains, members of each catenin subfamily were first
observed to bind the cytoplasmic tails of cadherin cell-cell adhesion proteins.
However, while the p120 subfamily members competitively associate with
membrane-proximal tail regions where they contribute to cadherin stabilization (42,
43), β-catenin or plakoglobin bind more distally and confer other attributes to the
complex, such as indirect cytoskeletal association (44-46). In addition to binding
and modulating cadherin functions, and engaging in nuclear activities, p120
subfamily members have now been well recognized to modulate small GTPases,
such as inhibiting RhoA and activating Rac (39, 47-53).

5

Figure 2. Linear structural representation of catenin family proteins. Distinct
from β-catenin, p120-catenin contains 9 repeats within its Armadillo domain. PDZ
binding motifs exist at the carboxyl-terminal end of p120 subfamily members, except
p120-catenin itself. This figure was modified/reproduced from a published paper,
Park et al, BBA, 2007 (39).
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In addition to the central Arm domains, which share only modest homology,
among catenins the amino- or carboxyl-terminal regions bear yet less resemblance
even within a catenin subfamily. These end domains engage in inter-protein
associations and also may modulate Arm-domain interaction in an intra-molecular
manner (30, 54-57). In the context of the canonical Wnt pathway, β-catenin’s aminoterminal domain is well known to encompass conserved GSK3β and CK1α
phosphorylation sites that when phosphorylated permit β-TrCP recognition (15-17).
Thus, this domain participates in determining the extent and activity of β-catenin’s
cytoplasmic / nuclear signaling pool. In addition, the β-catenin sub-family member
plakoglobin contains a similarly positioned destruction box, and its protein stability is
likewise modulated by canonical Wnt signaling (58, 59).

P120-catenin’s nuclear signaling

Previous work arising from our group and other researchers has outlined a new
role for p120-catenin in nuclear signaling. One context examined has been p120’s
response to canonical Wnt signals, where together with β-catenin, p120 modulates
expression of select Wnt gene targets such as Siamois (Xenopus), Cyclin-D1, and
Matrilysin (60-62). At such promoters, p120 recognizes and associates with Kaiso, a
transcriptional repressor of the BTB/POZ zinc-finger family that binds a Kaiso
consensus sequences (KCS) in DNA (60, 61). Once formed, the p120:Kaiso
complex is thought to dissociate from the gene promoter. Kaiso-directed gene
repression is then relieved, and enhanced transcriptional activity ensues (Figure 3).
8

In addition to Kaiso: KCS (DNA) interactions, for which conflicting reports have
arisen in certain gene contexts (63-65), Kaiso further recognizes methyl-CpG
islands present in gene control regions that are associated with repressive states
(66-69). However, at these sites in particular, no indications have yet arisen that
p120-catenin acts to relieve Kaiso-mediated repression, and furthermore, the
relationship between Kaiso’s roles at CpG-island versus sequence-specific DNA
binding sites is still unclear.

Recent evidence shows that Frodo (Functional regulator of Dishevelled in
ontogenesis) and the closely related Dapper functionally and physically interact with
Dsh (70-72), indicating Frodo’s involvement in the Wnt signaling pathway. Frodo
and Dapper act as positive or negative modulators of the canonical and noncanonical Wnt pathway in a context dependent manner (70, 73-76). Previous
investigation from our lab determined a new molecular mechanism of Frodo with
respect to the p120/Kaiso pathway. In that report, Frodo was shown to promote
p120’s stabilization upon their association. The depletion of Frodo decreased
p120’s level in Xenopus embryos, and thereby, some canonical Wnt gene targets of
p120/Kaiso pathway were affected (those having both TCF/ LEF & Kaiso binding
sites) (70) (Figure 3). Relating to the identification of potential molecular
mechanisms that modulate p120’s level, my work shows that upstream Wnt
pathway components stabilize p120-catenin protein levels, and that Frodo
selectively associates with, and stabilizes p120-catenin (not β−catenin).

9

Figure 3. A schematic pathway diagram of p120-catenin’s signaling to the
nucleus. In the presence of Wnt ligands, β-catenin is stabilized by defined
mechanisms. P120-catenin is stabilized by analogous means as β-catenin (shown
in my work), and by the association with Frodo. Increased levels of p120 leads to
the relocalization of the repressor Kaiso from the nucleus to the cytoplasm,
promoting increased transcription from certain Wnt target genes.
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P120-catenin was originally identified as a Src tyrosine kinase substrates. Since
its amino-terminal domain includes multiple serine/threonine and tyrosine
phosphorylation sites, this domain may act as a regulatory region (77). The
phosphorylation of p120-catenin has been proposed to be relevant to the
association of p120-catenin with cadherin or the stability of cadherin (78-83).
Despite considerable efforts to understand p120-catenin’s phosphorylation events,
the relationship of varied kinases to p120’s function in vivo have remained elusive.
Even the phosphorylation of p120 relating to cadherin function leaves the specific
phosphorylation sites to be determined. My recent findings have pointed to the role
of two different kinases in p120’s nuclear function, particularly GSK3β and Dyrk1A. I
have examined their contributions in the context of functional outcomes in Xenopus
embryos and mammalian cell lines.

P120-catenin isoforms

P120 subfamily members can further be distinguished from β-catenin/
plakoglobin in that each transcript bears multiple potential translational start sites
and arises from differential splicing events. These characteristics have added layers
of regulatory complexity to studies of p120 subfamily proteins (84, 85). Human
p120-catenin has potentially up to 48 isoforms due to the use of four alternative
start codons, and RNA-splicing events (Figure 4). Several domains have been
identified in p120, including coiled-coil domain found only in p120 isoform-1. The
12

regulatory domain, which includes multiple phosphorylation sites, exists in all
isoforms except isoform-4. P120-catenin is ubiquitously expressed in both adult and
fetal tissues. However the expression pattern of distinct p120 isoforms varies in
abundance between cell types and tissues. Its expression pattern was monitored
employing antibodies that specifically recognize the N-terminal domain of p120
(6H11) or p120’s C-terminal region (pp120) (85-88). Studies have shown that motile
cells such as fibroblasts and macrophages preferentially express the longest
isoforms (p120 isoform-1), while epithelial cells preferentially express short isoforms
(isoform-3 or -4) that associate with E-cadherin at cell-cell junction. Some nonadherent cells do not express detectable levels of p120. In human adult and fetal
tissues, the longest p120 isoform is mainly expressed in brain, heart, liver, lung,
spleen, small intestine, testis and ovary, while short isoforms are mainly expressed
in liver, lung, pancreas, colon, small intestine, prostate and ovary, and weakly in
heart, kidney, spleen and thymus (86). P120-catenin transcripts are also present in
multiple tumor tissues and cell types, with its pattern differing from the
corresponding normal tissue. For example, in pancreatic adenocarcinoma and lung
carcinoma, the level of the long p120 isoform is increased, whereas the level of the
long isoform is decreased in ovarian carcinoma (85). In Xenopus, there are two
isoforms identified. The longest isoform is xp120 isoform-1, thought to be analogous
to human p120 isoform-1. Xp120 isoform-2 is most homologous to human p120
isoform-3 (89). Recent evidence indicates that p120 isoforms have distinct
functions, perhaps including functions in tumor invasion and metastasis (84, 87). In
lung cancer, p120-catenin isoform-1 is highly expressed in the cytoplasm of highly
13

metastatic lung cancer tissues, and it co-localizes with Kaiso in the cytoplasm (9092). This suggests that p120-catenin isoform-1 may be associated with more
aggressive cellular phenotypes. Therefore, defining the molecular mechanisms that
govern distinct p120-catenin isoforms is likely to contribute to our knowledge on
catenin biology.

14

Figure 4. Schematic representation of the major p120-catenin isoforms. P120catenin has multiple isoforms, in humans up to a theoretical limit of 48 if considering
the four splicing variants and four alternative translational start sites. This figure was
modified/reproduced from a published paper, van Hengel, 2007 (87).
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The molecular mechanisms of Dyrk1A

Dual-specificity tyrosine-regulated kinase 1A (Dyrk1A) belongs to a novel
subfamily of protein kinases that engage in autophosphorylation on tyrosine
residues, while instead phosphorylating serine / threonine residues of other
substrates (93, 94). In mouse, Dyrk1A-/- null mutants display a general growth
delay and die during mid-gestation. Mice heterozygous for the mutation (Dyrk1A+/-)
show decreased neonatal viability and brain size in a region-specific manner, and
increased neuronal densities in some brain regions (95). Mouse and chick Dyrk1A
mRNA is expressed in neuroepithelial cells beginning at early CNS stages and is
asymmetrically distributed during mitoses of neuronal progenitor cells. A series of
studies have suggested Dyrk1A’s involvement in neuronal differentiation (96-98).

The human Dyrk1A genes maps to chromosome 21, falling into what is referred
to as the Down Syndrome critical region (DSCR) 21q22.2 (99). In the fetal brain of
Down syndrome patients, Dyrk1A is over-expressed and expected to contribute to
the phenotype induced by trisomy 21(100, 101). Interestingly, Down syndrome is
known to increase the risk of Alzheimer disease by three-to-five fold. Dyrk1A was
recently found to phosphorylate the microtubule binding protein tau, a component of
Alzheimer neurofibrillary tangles. Indeed, hyper-phosphorylation of tau is associated
with Alzheimer neurofibrillary tangles, and in both Alzheimer and Down syndrome
patients, Dyrk1A itself further accumulates in such tangles (102-105).

17

Thus, consistent with being expressed in neural progenitor cells and its
participation in dendrite differentiation, Dyrk1A is a candidate contributor in both
Down syndrome and Alzheimer disease. However, despite its implication in human
genetic disease, the molecular mechanisms underlying the impact of Dyrk1A gene
dosage imbalance in vivo remain largely unknown.

Human and rodent Dyrk1A are also highly expressed in the developing heart,
yet little is known of Dyrk1A’s roles in heart tissue. Intriguingly, relative to the normal
population, Down syndrome patients have increased chances of having congenital
heart defects (atrial, atrioventricular or ventricular septal defects, or patent ductus
arteriosus). One report found that Dyrk1A over-expression inhibits cardiomyocyte
hypertrophy, while Dyrk1A knockdown or inhibition had the opposing effect (106).

In brain tissue, p120-catenin appears to regulate dendritic spine and synapse
development (52). P120-catenin depletion in mouse forebrain resulted in dramatic
decreases in spine and synapse density. In rat brain, p120-catenin is highly
expressed and is potentially involved in morphogenetic events and plasticity of the
CNS (107, 108). In a small-scale screen to identify kinases that positively or
negatively regulate p120-catenin levels, I uncovered a new relationship between
Dyrk1A and p120-catenin. In my dissertation, I identify Dyrk1A as a positive
modulator of p120-catenin in both Xenopus embryos and mammalian cell lines.
These results suggest that one means by which Dyrk1A participates in
embryogenesis is through modulation of the Wnt/ p120/ Kaiso pathway, occurring
18

through the stabilization of p120 to relieve Kaiso-mediated repression. These
findings will conceivably contribute to establishing a new bridge between catenin
biology, especially p120-catenin, and Down syndrome pathology. Upstream control
of Dyrk1A remains an area of uncertainty, with questions including if it is responsive
to Wnt or other ligands. Therefore, more precise examination of the molecular
mechanisms relating to Dyrk in the content of Wnt signaling resides ahead.
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Chapter II

Materials and Methods

cDNA constructs
Standard recombinant DNA techniques were used to construct pCS2-based
plasmids harboring Xenopus laevis: Myc-p120-catenin, HA-p120-catenin (49), Mycβ-catenin, HA-β-catenin, Myc-ARVCF, HA-ARVCF (49), Myc-δ-catenin and HA-δcatenin (109). Myc-GSK3β-pXT7 and catalytically inactive mutant (K85R) (S. Sokol,
Mount Sinai School of Medicine) (110), HA-CK1α-pCS2 (Xi He, Harvard Medical
School) (111), Myc-Axin-pCS2 (P.S. Klein, U. of Pennsylvania) (12), xWnt8 (S.
Sokol, Mount Sinai Scholl of Medicine) (112), xWnt11 (R. Keller, University of
Virginia) (113, 114) and xWnt5a (R. Harland, University of California, Berkley) (115),
were kindly provided as indicated. GSK3β was subcloned into the pCS2-HA vector
for co-immunoprecipitation. Generated previously were pCS2 plasmids harboring
Myc-p120 deletion constructs, Myc-Frodo and HA-Frodo (70). The quadruple p120catenin point mutant (S6, S8, S11 & S15 4SA) was generated by PCR
amplification of HA-p120-catenin (in vector pCS2) as a template with 5’ mutated
primer as follows: P1204SA-F, 5’GGAATTCATGGATGAGCCAGAGGCTGAAGCTCCGGCCGCTATATTGGCCGCA
GTGAGAGCT-3’; P1204SA -R, 5’-
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AAGGCCTGACACGCTGATCTTCAGCATCACCAAGATTCAGTGATCCTCCAGCA
CTTACGGA-3’.

Embryo culture, microinjections, in vitro transcription and antisense
oligonucleotides
Fertilization, embryo culture and microinjections were conducted in accordance
with a standard methods (49). Embryos were microinjected with capped mRNA
synthesized in vitro (mMessage mMachine, Ambion). All pCS2-based constructs
were linearlized by using Not I restriction enzyme prior to in vitro transcription.
Gastrulation phenotypes, principally failure of blastopore closure, were visually
scored at embryonic stages 11-12. I employed an xDyrk1A-morpholino (xDyrk1AMO), and standard morpholino (STD MO, Gene Tool). xDyrk1A-MO sequences: 5’ATGAGACTTGAA AGAGGACGATGCA-3’.

Analysis and Gene Expression Using Real-time RT-PCR

Total RNA was prepared from stage 10.5 or 11.5 embryos that had been earlier
injected with morpholino or mRNA. Preparations employed Trizol followed by
RNase-Free DNase as instructed by Promega (RQ1 RNase-Free DNase). cDNA
was made using the Superscript first-strand synthesis system (Invitrogen), followed
by real-time RT-PCR and quantitation (Applied Biosystem, 7500 Real-time PCR).
Primers for RT-PCR were: Siamois, 5’- CCCAACTTCAGAAGGACCTAGATC-3’ and
5’-TGGGTAGGGCTGTGTATTTGA-3’; Wnt11, 5’-TGACAGCTGCAACCTCATGT-3’
21

and 5’-ACAGAGGGCTGTCAGTGCTT-3’; ODC, 5’-CGAGCGGATTATCTATGCA-3’
and 5’-GCGTATTTGATCTGGGAAA-3’.

Immunoprecipitation and immunoblot analysis

Immunoprecipitation and immunoblotting employed monoclonal antibodies
directed against Myc (9E10), HA (12CA5), p120-catenin (mouse/ human pp120, BD
Transduction; mouse/ human 6H11, Santa Cruz), and GSK3β (mouse, BD
Transduction). Polyclonal antibodies included those directed against β-catenin and
p120-catenin, that were raised in our lab (70). Antibodies directed against Frodo
were provided by Dr. Sergei Sokol’s lab, while rabbit polyclonal antibodies directed
against Dyrk1A were commercially obtained (Abcam). For immunoprecipitations,
procedures were largely performed as described (49). Whole-embryo lysates were
prepared using 0.5% Triton X-100 buffer (0.5% Triton X-100, 10 mM HEPES [pH
7.4], 150 mM NaCl, 2 mM EDTA, 2 mM EGTA), inclusive of a proteinase inhibitor
cocktail (Sigma). Interference from the IgG heavy chain in immunoblot analyses
was reduced by employing TrueBlotTM anti-mouse IgG IP Beads, and Mouse
TrueBlotTM ULTRA:Horseradish Peroxidase (HRP) anti-mouse IgG (eBioscience).
Embryos were lysed in 0.5% Triton X-100 buffer (20 µl per embryo), in the presence
of a proteinase inhibitor cocktail (Sigma). After centrifugation (14000 rpm, 20 min),
the supernatant fraction was denatured in 5x SDS sample buffer (200 mM Tris-Cl
[pH 6.8], 40% glycerol, 8%SDS, 0.08% Bromophenol Blue), followed by incubation
at 95°C for 5 min. Half-embryo equivalents were resolved by SDS-PAGE and
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transferred onto nitrocellulose membranes. Immunoblotting and antibody
incubations took place in 2% bovine serum albumin-TBST (25 mM Tris-HCl [pH
7.8], 125 mM NaCl, 0.5% Tween 20). SuperSignal WestPico (Pierce Biotechnology,
Inc.) reagents were utilized to detect HRP-conjugated secondary antibodies.

Mammalian cell culture and immunofluorescence staining

HeLa, 293T and MDA-MB-435 cells were purchased from ATCC and maintained
in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum. MDAMB-231 cells were kindly provided by Dihua Yu (UT MD Anderson Cancer Center).
Using Lipofectamine 2000, cells were transiently co-transfected with DNA
constructs such as Myc-Kaiso and HA-Dyrk1A. 24 hours after transfection or the
indicated time after treatment, cells were fixed with 4% PFA (paraformaldehyde) for
10min, blocked with 5% goat serum in PBS and immunostained with anti-Myc
antibody (9E10). Fluorescence images (Nikon ECLIPSE E800 microscope) were
recorded using SPOT advanced software.

Transfection and RNA interference

siRNA oligonucleotide sequences directed against the transcripts of Axin1&2 or
LRP5&6 were gathered from published reports (20), and synthesized by Applied
Biosystems. The proprietary duplex negative control siRNA was purchased from
Ambion. Duplex oligonulceotides were directed against the target sequences: Axin1
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5’-GGCGAGAGCCATCTACCG AAA-3’; Axin2 5’-GCAGACGATACTGGACGATCA3’; LRP5 5’-CCAACGACCTCACCATTGTCT-3’; and LRP6 5’AGACATTGTTCTGCAGTTAGA-3’ ; Dyrk1A-1 5’-TTAAGGATGCTTGATTATGAC3’; Dyrk1A-2 5’-AAACTCGAATTCAACCTTATT-3’. siRNA oligonucleotide
sequences of Dyrk1A were gathered from published reports (116, 117). For
transfection of siRNA alone into 6-well plates, LipofectamineTM RNAiMax
(Invitrogen) was employed (50pmol/well). When DNA plasmids were transfected
along with siRNA, Lipofectamine 2000 (Invitrogen) was used. After transfection and
incubation for 48-72 hours, cell lysates were collected using M-PER mammalian
protein extraction reagent (Thermo Fisher Scientific Inc.), and proteins detected by
immunoblotting.

Pulse-Chase Analysis
HeLa-S3 cells were transiently transfected with (HA epitope tagged) pCS2-HAp120 or pCS2-HA-p1204SA. After 24 hours, cells were washed and preincubated for
1 hour with Met/Cys-free DMEM made 10% in FBS. The medium was then replaced
with fresh Met/Cys-free medium containing 40 µCi/µl of [35S]-Met/Cys, and
incubated for 1 hour. The cells were washed and incubated in complete medium,
and 2 mg of cell lysates were immunoprecipitated with anti-HA-7 agarose (Sigma).
The samples were subjected to 8% SDS-PAGE followed by autoradiography.

In Vitro Kinase Assay
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For in vitro kinase assays, flag-tagged p120 N-term wild-type or 4SA-mutant
(amino acids 1-280), and flag-tagged GSK3β or HA-tagged Dyrk1A wild-type and
Kinase Dead (KD) were synthesized in vitro (TnT system, Promega). Each p120
construct was incubated with kinases or kinase-dead enzyme at 30°C for 90
minutes in the presence of [32P]γ-ATP. Substrate proteins were then
immunoprecipitated, with isotope labeling resolved by SDS-PAGE/ autoradiography.
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Chapter III

Negative regulator of p120-catenin and p120 subfamily members: canonical
Wnt signals/components modulate p120-catenin isoform-1, ARVCF and δ-catenin
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Result

(Chapter III)

GSK3β modulates p120-catenin stability

Given that our prior work suggesting similarities in p120-catenin and β-catenin
regulation (70), I directly investigated the involvement of established components of
β-catenin’s destruction machinery in p120 regulation. Studies were initially
performed to examine the impact of expressing exogenous GSK3β on p120’s level
in early Xenopus embryos. Based upon our prior findings to show that inhibiting
GSK3 via LiCl increased endogenous p120-catenin levels, it was speculated that
GSK3β ectopic expression should decrease p120-catenin levels (70). Indeed, wildtype GSK3β and CK1α reproducibly reduced the level of Myc-tagged xp120
isoform-1 (longest isoform; translation beginning at p120’s most upstream ATG
site), while CK1ε or a kinase-dead form of GSK3β (KD) (negative-control), did not
have statistically significant impact upon p120 (Figure 5A, and data not shown).
Unexpectedly, lower as opposed to intermediate or sometimes even high GSK3β
expression (5 pg versus 10pg, or in some cases 100 pg mRNA), produced modestly
greater reductions in ectopic or endogenous p120-catenin isoform-1 levels and
functional consequences in Xenopus embryos (Figure 5A, 5B and 5C), as
discussed later in relation to other findings (Figure 10 & Discussion). Ectopically
expressed p120-catenin was employed in these initial studies given that a large
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proportion of endogenous p120 is bound to cadherin, which as established for βcatenin, would be expected to exhibit less sensitivity to Wnt-pathway regulation.

I next tested for a functional relationship between p120 and GSK3β using a
phenotypic assay in vivo. As predicted, p120-catenin over-expression resulted in
gastrulation failures in a significant fraction of embryos (49). However, when a
carefully titrated dose of GSK3β was co-injected with p120, I observed significant
rescue of the gastrulation phenotypes (Figure 5D; compare the first two bars).
Kinase-dead GSK3β did not produce such rescue effects (GSK3β KD, negative
control), while a titrated dose of Axin appeared to have modest rescuing activity.
To complement over-expression assays, I next used loss-of-function experiments.
As morpholinos to deplete GSK3 have not been well characterized for work in
Xenopus, we instead used a proven short-hairpin/ shRNA to block GSK3 function in
HeLa cells (118). As anticipated, p120-catenin protein levels were elevated upon
the depletion of endogenous GSK3, as assessed using immunofluorescence
analysis as well as immunoblotting (Figure 5E). Noteworthy in our
immunofluorescence images is p120’s increased presence in both the cytoplasmic
and nuclear compartments, relative to negative control shRNA transfected cells.
Collectively, these data (Figure 5) propose that p120 is subject to modulation by
GSK3β.
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Figure 5. GSK3β modulates p120-catenin protein levels.
(A) Myc-p120-catenin mRNA (0.5ng) was microinjected into each blastomere of 2cell stage embryos with the indicated levels (in vitro transcribed mRNA) of GSK3β
kinase, GSK3β kinase-dead mutant (KD), CK1α or CK1ε. Embryos were harvested
at stages 10-11 for immunoblotting with anti-Myc antibody, with actin serving as an
internal loading control. The right panel quantities Myc-p120 protein levels
normalized to actin, using data from four independent experiments. (B) Increasing
total doses of Myc-GSK3β were microinjected into both blastomeres at the 2-cell
stage. Embryos were collected at late-gastrula stage 12, and endogenous p120catenin and β-catenin levels respectively visualized via immunoblotting. (C) Gross
gastrulation effects following exogenous GSK3β expression. Although many direct/
indirect GSK3β targets are likely to have been affected, it is interesting that the
dose-dependent effects on gastrulation mirrored the dose-dependent GSK3β effects
upon p120 and β-catenin levels in panel (B). (D) Gastrulation (blastopore closure)
failure following exogenous p120-catenin expression (0.5 ng mRNA injection),
versus rescue upon co-expression with GSK3β mRNA (5 pg), or more partial
rescue using co-expressed Axin (5pg). (E) Either Venus-sh-random or Venus shGSK3 and Myc-xp120-catenin were co-transfected into HeLa cells as indicated. 48
hours after transfection, cells were assayed for Myc-p120 using
immunofluorescence or immunoblotting (left versus right panels). For
immunofluorescence, cells were fixed with 4% PFA and probed for Myc-p120
followed by Texas red-conjugated anti-mouse visualization. For immunoblotting,
tubulin served as an internal loading control. This figure was modified/reproduced
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with permission from the Journal of Cell Science (119).
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P120-catenin is regulated by the ubiquitin-proteasome pathway

Given β-catenin’s phosphorylation by CK1α/ GSK3β, followed by degradation
via the proteasomal pathway, I examined whether p120 is regulated in a manner
similar to that of β-catenin. To better resolve the p120-catenin signaling pool, we
employed MDA-MB-231 and MDA-MB-435 cells, which are largely E-cadherin
deficient, in addition to 293T cells, which express E-cadherin. MDA-MB-231, MDAMB-435 and 293T cells were incubated with the proteasome inhibitor MG132, and
endogenous p120 was monitored via immunoblotting. As expected, p120-catenin
was stabilized by MG132 in a dose-dependent manner in all cell lines tested (Figure
2A). To detect endogenous p120-catenin, we used two previously characterized
anti-p120 monoclonal antibodies, pp120 and 6H11 (120). 6H11 is directed against
an amino-terminal epitope, which selectively resolves the isoform-1 generated from
the most upstream translational start site. pp120 antibody detects all p120 isoforms,
because it recognizes a carboxyl-terminal epitope present across most p120
translation products. In the cell lines employed here, pp120 detects two
predominantly expressed products thought to be isoforms-1 and -3. Inhibition of the
proteasome pathway via dose-dependent titration of MG132 elevated p120 isoform1 levels in all cell lines tested, with an observable yet lesser impact upon isoform-3,
as was evident in MDA-435 cells in which E-cadherin is deficient (Figure 6A).
Further analogous to β-catenin (17), p120 ubiquitination was clearly evident upon its
co-expression with HA-ubiquitin in HeLa cells. Likewise as expected, being
dependent upon GSK3β, such p120 ubiquitination dropped when cells were
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incubated with the GSK inhibitor LiCl (Figure 6B). Since CK1α is a priming kinase
for GSK3β in the β-catenin degradation pathway, I examined the effect of incubating
embryos in the presence of the CK1 inhibitor D4476. Consistently, D4476 treatment
raised expressed p120 levels, as was predicted and clearly observed for β-catenin
(positive control) (Figure 6E). Consistent with our Xenopus embryo and exogenous
expression data, endogenous p120 isoform-1’s level in mammalian cells was also
increased when MDA-435 or 293T cells were exposed to D4476 (Figure 6D).
Additionally, p120’s sensitivity to GSK3 was supported in pulse-chase data, where
LiCl or MG132 treatment prolonged the half-life of both endogenous and exogenous
p120-catenin (Figure 6F and data not shown).

33

Figure 6. Proteasome mediated degradation appears to modulate p120catenin levels.
(A) MDA-231, MDA-435 and 293T cells were treated with varying doses of the
proteasome inhibitor MG132 (0, 2, 5, 10, 25 µM). After 6 hours, cells were
harvested for immunoblotting with anti-p120 antibody (6H11 & pp120). (B) Mycp120-catenin was co-transfected into HeLa cells with HA-ubiquitin. After 24 hours,
cells were treated with LiCl (25mM) for 4 hours to block GSK3β function. Cells were
harvested and HA-ubiquitinated proteins immunoprecipitated, followed by Myc-p120
immunoblotting. Endogenous β-catenin was used as a positive ubiquitination
control. (D) MDA-435 and 293T cells were treated with varying doses of the CK1
inhibitor D4476 (0, 2, 5, 10, 25 µM). P120-catenin was visualized using an antibody
directed against it (pp120), and endogenous β-catenin served as an endogenous
positive control. (E) Single cells of 2-cell embryos were injected with Myc-p120catenin and Myc-β-catenin mRNA (0.1ng mRNA each), and treated for 24 hours
with varying concentration of the CK1 inhibitor D4476 (10, 50, 200 µM) in the
presence of Fugene6. Anti-myc-antibody was employed to detect both p120-catenin
and β-catenin. (F) HA-p120-catenin was expressed in 293T cells. Following a 1
hour incubation with 40 µCi/µl of 35S-Met/Cys, cells were treated at the indicated
times with 0.5% NP-40 lysis buffer. HA-p120 was immunoprecipitated using anti-HA
antibodies, and resolved by SDS-PAGE followed by autoradiography (band
densities quantitated using ImageJ). This data is collected from two independent
experiments. This figure was modified/reproduced with permission from the Journal
of Cell Science (119).
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Inhibition of the destruction machinery recruits Kaiso to the cytoplasm

Since expression of exogenous p120 recruits the transcription repressor Kaiso from
the nucleus to the cytoplasm (60, 121), we next examined whether endogenous
p120 stabilization correlates with a similar outcome. As predicted, Kaiso relocalized
to the cytoplasm in the coordinate presence of proteasome inhibitor (MG132) and
GSK chemical inhibitor (LiCl) (Figure 7A), potentially through known effects upon
p120 stabilization (Figure 5E&6A). LiCl or MG132 alone produced a reproducible
but considerably subtler effect on Kaiso’s relocalization, consistent with its lesser
protection of p120 relative to the combined treatment (data not shown). To ask if
endogenous Kaiso displays a similar outcome as exogenous Kaiso, I employed
MDA-435 cells, which express neither E-cadherin RNA nor protein. Endogenous
Kaiso appears to relocalize from the nucleus to the cytoplasm in MDA-435 cells,
when employing a monoclonal antibody directed against Kaiso (6F) (Figure 7B).
Together, the data from Figures (5, 6 & 7) suggest that endogenous p120-catenin is
subject to some of the same regulatory processes established for β-catenin in the
context of the canonical Wnt signaling pathway.
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Figure 7. P120 stabilization via inhibition of the proteasome pathway
promotes Kaiso’s relocalization.
(A) HeLa cells were grown on cover slips, transiently transfected with Myc-Kaiso
and treated with MG132 (10µM) and LiCl (50µM). Cells were fixed with 4% PFA for
10 min, blocked with 5% goat serum in PBS and immunostained with anti-Myc
antibody. (B) MDA-435 cells were treated with MD132 and LiCl as indicated in (A),
then fixed and immunostained with anti-Kaiso antibody (6F). This figure was
modified/reproduced with permission from the Journal of Cell Science (119).
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Association of destruction complex components with p120-catenin

Several in vivo and in vitro reports show that β-catenin associates with Axin, βTrCP, GSK3β and CK1α (10, 15, 111). Given that p120-catenin’s levels and
functions outcome in vivo are modulated by the destruction complex (Figure 5 & 6),
we assayed if p120 might likewise engage in such associations. Since a significant
fraction of endogenous p120 is in complex with cadherins at the membrane as
opposed to being within an accessible signaling pool in the cytoplasm, coimmunoprecipitations were performed from Xenopus embryo extracts using
ectopically expressed proteins. We first tested for the association of p120 with
GSK3β. While weakly apparent in immunoblots, the p120:GSK3β complex was
reproducibly resolved relative to GSK3β KD, serving as a negative control (Figure
8A, see also Figure 9B). We next examined Axin, which is known as a scaffolding
protein, and thus interacts with multiple components of β-catenin’s destruction
complex. In precipitations conducted in either direction (reverse precipitation not
shown), Axin interacted with p120 as resolved in immunoblotting (Figure 8B; Kaiso
negative control). P120 was also detected in complex with CK1α, the priming
kinase that acts upon β-catenin immediately prior to GSK3β (Figure 8C; Kaiso and
C-cadherin serving as negative controls). I also resolved association of the E3
ubiquitin ligase β-TrCP with p120, relative to negative control IgG
immunoprecipitates (Figure 8D). Given the data presented here with ectopically
expressed proteins, I finally asked if endogenous p120 associates with endogenous
GSK3β. Employing established GSK3β, p120 and β-catenin antibodies, I
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immunoprecipitated endogenous GSK3β and resolved the p120:GSK3β complex in
293T and MDA-435 cells (Figure 8E). Thus, in an in vivo context, p120-catenin
directly or indirectly interacts with some of the key proteins known to regulate βcatenin stability in the canonical Wnt pathway.
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Figure 8. P120-catenin associates with destruction complex components.
(A) HA-p120-catenin (1ng) was co-injected with either Myc-GSK3β or Myc-GSK3β
KD (0.5ng) into both blastomeres of 2-cell embryos. Myc-GSK3β
immunoprecipitates were immunoblotted with anti-HA antibody to detect p120. (B)
HA-Axin (0.5ng) was microinjected with Myc-p120-catenin (1ng) or Myc-Kaiso (1ng)
into both blastomeres of 2-cell embryos, subsequently harvested at gastrulation.
Anti-HA antibody (Axin) immunoprecipitates were blotted with anti-Myc-antibody to
detect p120-catenin versus Kaiso (negative control). (C) HA-CK1α was injected
into both blastomere of 2-cell embryos along with Myc-p120, Myc-C-cadherin or
Myc-Kaiso, and embryos harvested at early-mid gastrulation (stage 10-11). This
was followed by anti-HA immunoprecipiation (CK1α), and then anti-Myc (p120, or
negative controls C-cadherin or Kaiso), or anti-HA immunoblotting (CK1α). (D) The
association of Myc-β-TrCP (0.5ng) and HA-p120-catenin (1ng) was resolved using
methods analogous to those used in (C). (E) 293T and MDA-435 cells were grown
in 10cm dishes, and lysates immunoprecipitated for endogenous GSK3β (BD
Transduction). The association of endogenous p120-catenin (6H11) with GSK3β
was resolved by immunoblotting (β-catenin positive control). This figure was
modified/reproduced with permission from the Journal of Cell Science (119).
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P120’s amino-terminal domain associates with GSKβ and CK1α

The amino-terminal domain of β-catenin includes four serine residues
phosphorylated by CK1α and GKS3β, and thus provides the platform for their
association (15, 122). As a first step in assessing p120-catenin phosphorylation, we
searched for potential GSK3β phosphorylation sites. Three evolutionally conserved
GSK3β phosphorylation residues were identified, with one being amino-terminal and
two residing in the Armadillo repeat domain. P120’s amino-terminal region
interestingly harbors a 3DSX3SX2SX3S15 motif comparable to the GSK3β-sensitive
site existing in β-catenin (Figure 10A) (16). To map p120’s interaction domains with
GSK3β and CK1α, Hong Ji, one of our lab members, generated a series of p120
deletion constructs (a-f) (Figure 9A). Using these p120 deletion constructs, I
performed co-immunoprecipitations from Xenopus embryo extracts after the
microinjection of those constructs with either GSK3β or CK1α. Constructs
containing p120’s amino-terminal domain associated with GSK3β (fl, b, c & e),
whereas p120 constructs lacking this region (a, d & f) did not (Figure 9B). I then
tested if the p120 deletion mutant lacking the amino-terminal region is ubiquitinated.
Consistent with the association of p120 amino-terminus with GSK3β, only the
construct (d) lacking p120’s amino-terminal region were negative for ubiquitination
(Figure 9C). Based on such findings, I next examined if the CK1α priming kinase of
β-catenin (primes for GSK3β), associates with the analogous region of p120catenin. Employing a similar co-immunoprecipitation strategy, I resolved the
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interaction between CK1α and p120’s amino-terminal domain (c), but not with a
p120 mutant construct (d) which lacks this region (Figure 9D). Thus, in keeping with
our prior findings, this evidence suggests that p120 and β-catenin engage in shared
protein interactions reflecting their similar biochemical and likely functional
responses to Wnt signals.
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Figure 9. Mapping of p120 association with GSK3β, CK1α and ubiquitin.
(A) Myc-tagged p120-catenin deletion constructs (a-f). The table summarizes the
relative p120-construct:GSK3β association as shown in (B). (B) HA-GSK3β (0.5ng
mRNA) was co-expressed with varying p120-catenin deletion constructs (a-f)
(0.5ng), followed by HA-GSK3β immunoprecipitation and Myc-construct
immunoblotting. (C) Either Myc-p120-catenin (fl) or Myc-ΔN-p120-catenin
(construct d) was co-transfected with HA-tagged ubiquitin in HeLa cells. Following
HA-ubiquitin immunoprecipitation, co-associated (versus not) Myc-p120 constructs
were visualized via immunoblotting. (D) Myc-p120 constructs (fl, c & d) (0.5ng
mRNA) were co-injected with HA-CK1α (0.5ng) in both blastomeres of 2-cell
embryos. Gastrula embryo extracts were immunoprecipitated for HA-CK1α and
blotted for Myc-p120. Right panel, lysate indicates Myc-p120 construct expression.
This figure was modified/reproduced with permission from the Journal of Cell
Science (119).
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P120 point mutant differs in destruction-complex responsiveness

To evaluate whether the potential GSK3β or CK1α sites identified in p120’s
amino-domain are in fact relevant to its sensitivity to destruction complex
components, I designed a p120 compound point mutant in which four serines were
mutated to alanines (p1204SA/ Ser  Ala: Ser6, Ser8, Ser11, Ser15) (Figure 10A).
P120-catenin full-length (fl, comparable to p120 isoform-1) versus p1204SA mutant
were microinjected into Xenopus embryos, and their protein stability was monitored
with immunoblotting in response to the presence of GSK3β. While p120-fl levels
were consistently decreased upon GSK3β co-expression (Figure 10B compare
lanes 1 & 2, see also Figures 1A & 10A), levels of the mutant were in contrast not
lowered (Figure 10B compare lanes 3 & 4).

In fact, surprisingly, p1204SA’s level was reproducibly increased upon coexpression with GSK3β in Xenopus embryos. Apparently, a direct or indirect
protective effect of GSK3β was unmasked in producing the p1204SA mutant. This
possibility may also have been resolved in the unexpected lesser impact upon p120
levels/ degradation of intermediate (10pg or in some cases higher) GSK3β levels
relative to lower (5pg) or higher (100pg) GSK3β levels (Figure 5A & 5B). I
hypothesize that at intermediate GSK3β levels, wild type p120 may become
susceptible to direct or indirect GSK3β effects that are protective in nature
(phosphorylation/ other), whereas lower or higher GSK3β activity largely acts at
negative-regulatory sites that we resolved. Indeed, other potential but more distal
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GSK sites have been identified in p120 such as the site just upstream of the Arm
domain (Ser199 amino-acid) (123). Evidence supporting GSK3’s modification of
such additional predicted sites was not obvious, however, in our in vitro kinase
assays (Figure 12, and data not shown). Alternative possibilities include GSK3β
phosphorylation of LRP5/6, leading to destruction complex inhibition via recruitment
of either Axin or GSK3β to the membrane, followed by β-catenin stabilization (18,
19, 24, 25). Whatever the underlying mechanistic explanation, mutation of p120’s
conserved four amino-terminal serines (p1204SA/ Ser  Ala: Ser6, Ser8, Ser11,
Ser15) protects p120 from destruction complex-mediated degradation.

In addition to candidate kinase sites, study of p120’s primary sequence pointed
to a conserved potential β-TrCP recognition motif, DSEXXS (16, 122). In common
with β-catenin, this motif resides adjacent to p120’s putative amino-terminal CK1α/
GSK3β phosphorylation sites (Figure 10A). Indeed, employing a coimmunoprecipitation/ immunoblotting approach, the association of p120 with β-TrCP
was resolved, whereas our phosphorylation mutant p1204SA exhibited significantly
reduced β-TrCP co-association (Figure 10C, compare lane 2 with lanes 4 and 6).
These observations are consistent with β-catenin’s known regulation, wherein
phosphorylation is required for β-TrCP recruitment (15). Given this outcome, I next
tested if p1204SA would prove less susceptible to ubiquitination relative to wild-type,
and tested this possibility in HeLa cells. Indeed, while p120 appears to have a
strong ubiquitination signal, poly-ubiquitination upon p1204SA was greatly reduced.
Interestingly, mono- or di-ubiquitinated forms showed lesser differences when
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comparing p120 versus p1204SA (Figure 10D). Consistent with reduced
ubiquitination, pulse-chase data indicated that p1204SA has a prolonged half-life
relative to native p120 (approximately 3 versus 1.5 hours) (Figure 10E).
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Figure 10. Phosphorylation dependent p120-catenin ubiquitination and
proteasomal degradation. (A) Cross-species sequence alignment of p120-catenin
regions harboring conserved predicted GSK3β phosphorylation and ubiquitination
sites. Highlights shown in each region include conserved serine residues, and a
DSEXXS motif for β-TrCP recognition. (B) HA-p120 (0.3ng mRNA), versus the HAp1204SA point mutant (4SA, see Figure 6A, 0.3ng), was co-injected with HAGSK3β (0.1ng) into both cells of 2-cell embryos. Gastrula embryo lysates (stages
11-12) were immunoblotted for the HA-p120 constructs, revealing a differing
response to GSK3β. (C) HA-p120 versus HA-p1204SA (0.5ng) were co-injected
with Myc-β-TrCP (0.5ng) into one blastomere of 2-cell embryos. Gastrula embryo
lysates were immunoprecipitated for Myc-β-TrCP and assayed for co-associated
HA-p120 or HA-P1204SA. (D) Myc-p120 or Myc-p1204SA was co-transfected with
HA-ubiquitin into HeLa cells. HA-ubiquitin was immunoprecipitated and immunoblotting used to detect ubiquitinated Myc-p120 versus Myc-p1204SA. (E) The half
lives of HA-p120 versus HA-p1204SA were monitored by pulse-chase analysis.
Following 1hour pulse-chase with [35S] Met/Cys, HeLa cells transfected with HAp120 and HA-p1204SA were harvested at the indicated times, and anti-HA
immunoprecipitates were resolved by SDS-PAGE and visualized by
autoradiography (quantitation of band intensities employed Image J, and was
normalized to the zero time point). This data is representative of two independent
experiments. This figure was modified/reproduced with permission from the Journal
of Cell Science (119).
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Stabilized p120 point mutant exhibits an enhanced impact upon target gene
expression

At the functional level, p120-catenin has a number of in vivo activities including
the capacity to relieve Kaiso-mediated repression of target genes containing
sequence-specific binding sites (KCS). Given that p1204SA shows an expanded halflife, we next asked if the transcriptional activity of p1204SA is elevated above that of
wild-type p120, using Wnt-11 and Siamois as direct endogenous gene readouts
(62). Employing semi-quantitative RT-PCR (Figure 11A), and real-time PCR (Figure
11B), I observed induction of Wnt-11 expression by p1204SA (relief of Kaisomediated repression) to a greater extent than wild-type p120-catenin, even though
p1204SA was reproducibly expressed at lower levels relative to wild-type (Figure
11B, compare lanes 3 & 4). Furthermore, the p1204SA mutant proved more effective
in promoting the expression of xSiamois (Figure 11C), another direct p120/ Kaiso
(as well as β-catenin/ TCF/ LEF) gene target (61). These data indicate that
stabilized p120 (p1204SA) exhibits more potent gene regulatory outcomes than wildtype p120-catenin, analogous to the β-catenin context (124, 125). We next
conducted in vitro kinase assays with p120, CK1 and GSK3β. As occurs for βcatenin (15), phosphorylation of p120 was faint but reproducible, suggesting it is a
direct GSK3β/ CK1α target (Figure 12 & data not shown).
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Figure 11. Stabilized p120-catenin mutant exhibits increased capacity to
activate target gens. (A) Myc-GSK3β (5pg mRNA) or Myc-Kaiso (0.25ng) was
microinjected with HA-p120 versus HA-p1204SA (0.25ng) into one blastomere of 2cell embryos. Total mRNA injection loads were equalized using β-galactosidase
mRNA. Gastrula embryo cDNA (stage 10-12) was subject to RT-PCR to assay
endogenous xWnt-11 transcript levels. Band intensities are indicated relative to βgal control (set at 1), following normalization to the Histone H4 internal loading
control. (B) Myc-Kaiso or β-gal (negative control) was injected alone (0.25ng), or
Myc-Kaiso was co-injected with HA-p120 versus HA-p1204SA (0.25ng), into one
blastomere of 2-cell embryos. Gastrula embryo cDNA was assayed by real-time RTPCR for xWnt-11 transcript levels. (C) Across varying doses, the stabilized p1204SA
mutant increases xSiamois luciferase activity to a greater extent than wild-type
p120-catenin (p1204SA exhibits greater relief of Kaiso-mediated repression of
xSiamois). xSiamois luciferase reporter plasmid (0.25ng) was co-injected with the
indicated amounts of HA-p120 versus HA-p1204SA. Gastrula embryos (stage 12-13,
eight embryos per condition) were collected to quantities luciferase activity. This
figure was modified/reproduced with permission from the Journal of Cell Science
(119).
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Figure 12. In vitro assay of GSK3β and CK1α kinase activity upon p120 For in
vitro kinase assays, flag-tagged p120 N-term wild-type or 4SA-mutant (amino
acids1-280), and flag-tagged GSK3β were synthesized in vitro (TnT system,
Promega). Each p120 construct was incubated with flag-GSK3β and CK1 (NEB
P6030) at 30°C for 90 minutes in the presence of [32P]γ-ATP. Substrate proteins
were then immunoprecipitated, with isotope labeling resolved by SDS-PAGE/
autoradiography. Comparing lanes 4 & 6, wild-type p120-catenin is very modestly
labeled in the presence of GSK3β and CK1, whereas the 4SA mutant shows no
detectable phosphorylation. This is consistent with modest CK1/ GSK3β labeling
observed upon β-catenin in vitro (15). Robust GSK3β auto-phosphorylation serves
as a positive control (lane 3, 4, 5 and 6). This figure was modified/reproduced with
permission from the Journal of Cell Science (119).
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Shared mechanisms modulate the metabolic stability of multiple p120-catenin
sub-family members

P120-catenin is the prototypical member of the p120-catenin sub-family
consisting of p120-catenin itself, ARVCF-catenin, δ-catenin and p0071-catenin (39).
These p120-catenin family members have certain shared features, such as a
central Armadillo domain (9 repeats as opposed to the 12 in β-catenin/ plakoglobin),
their interaction with cadherin membrane-proximal regions (β-catenin/ plakoglobin
instead bind membrane-distal regions), and their modulation of small GTPases (βcatenin/ plakoglobin apparently lack this functionality). Based upon my findings on
p120-catenin, I next asked if other p120 sub-family members might associate with
and respond to destruction complex components of the Wnt pathway. Probing
Xenopus embryo extracts, I first tested if one of the main components of the
destruction complex, Axin, had an impact upon ARVCF and δ-catenin levels.
Serving as positive controls, β-catenin and p120 levels were decreased in the
presence of Axin (Figure 13A & 14A). Likewise, ARVCF and δ-catenin were
considerably decreased upon Axin co-expression, whereas negative controls
(xKazrin and EWS) produced no response to Axin (Figure 13A). I further asked
whether ARVCF- and δ-catenin interact with Axin, as we demonstrated above for
p120, and as known to occur for β-catenin. Indeed, in common with p120-catenin
and β-catenin (positive controls), both ARVCF and δ-catenin associated with Axin,
relative to negative controls such as xDyrk and xKaiso (Figure 13B & 13C).
Although full-length δ-catenin exhibited less association with Axin than did β-catenin
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or p120, shorter forms of δ-catenin, which likely arose from endogenous proteolytic
processing or incomplete translation, showed strong association with Axin (Figure
13C).
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Figure 13. Axin promotes the degradation of p120-catenin subfamily
members.
(A) The indicated Myc-tagged p120 sub-family members (1ng mRNA each) were
co-injected with Myc-Axin (0.1ng) into both blastomere of 2-cell embryos, and
gastrula embryo lysates were Myc-immunoblotted. HA-Kazrin and HA-EWS (1ng
each) were co-injected with Myc-Axin (0.5ng) as negative controls for Axin’s effects,
while Actin and GAPDH served as internal loading controls. (B) The HA-tagged
p120 sub-family members (1ng each) were co-injected with Myc-Axin (1ng) into
both blastomere of 2-cell embryos. Gastrula (stage 11-12) embryo lysates were
immunoprecipitated for Myc-Axin, followed by immunoblot for HA-tagged p120 subfamily catenins. The bottom panel confirms Axin immunopreciptiations. HA-Kaiso
and HA-Dyrk serve as negative controls. (C) HA-Axin was co-injected with either
Myc-tagged β-catenin or δ-catenin into both blastomere of two-cell embryos. HAAxin immunoprecipitates were immunoblotted with anti-Myc antibody to detect βcatenin or δ-catenin. This figure was modified/reproduced with permission from the
Journal of Cell Science (119).
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Canonical Wnt signals modulate p120-catenin

Generally, β-catenin destruction is inhibited upon activation of the canonical Wnt
pathway. In addition to more recently reported mechanisms (29), canonical Wnt
signals activate intracellular Dishevelled and LRP5/6, which block the association of
β-catenin with the destruction complex by membrane recruitment of the core
component Axin and GSK3β, followed by LRP phosphorylation by a dual-kinase
mechanism (18, 19). Membrane recruitment of Axin, together with associated
GSK3β, permits β-catenin’s release to the cytoplasmic signaling pool by a
mechanism that remains somewhat unclear. Released β-catenin can then
accumulate in the cytoplasm and enter the nucleus, facilitating its activation of Wnt
target genes such as xSiamois, c-Myc and Cyclin-D1. Given that p120’s level is
diminished by presence of the destruction machinery, I wished to extend this
mechanism conceptually to p120-catenin. To confirm that Wnt signals promote
p120 levels due to destruction complex inhibition, I co-injected p120-catenin with
GSK3β in the presence versus absence of the Wnt8 ligand, one of the typical
canonical Wnt-ligands in Xenopus ( in some contexts it has non-canonical activity)
(8, 9). I also assessed the impact of co-expressing Frodo with GSK3β. Although the
role of Frodo in Wnt signaling remains unclear and somewhat controversial, it
associates with Dsh and engages in Wnt signaling (72). We earlier reported its
positive regulation of p120-catenin levels (70). As predicted, expression of Wnt8 or
Frodo reproducibly protected p120-catenin from the negative effects of GSK3β
(Figure 14A, compare lanes 5 & 7 with lane 2). Further, in keeping with prior data
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showing the partial capacity of Axin to rescue developmental phenotypes produced
by ectopically expressed p120 (Figure 5D), we found that Axin facilitates p120catenin’s degradation (Figure 14A, compare lane 3 with 1). In a dose dependent
manner, Wnt8 countered Axin mediated destruction of p120 (Figure 14C). Frodo
likewise protected p120 from the negative effects of Axin (Figure 14A, compare lane
8 with 3), as if also countered co-expressed GSK3β (Figure 14A, compare lane 5
with 2). At the low levels of GSK3β and Axin exogenously expressed, I was not able
to monitor the effects upon endogenous β-catenin. However, higher GSK3β
expression caused endogenous β-catenin’s degradation (Figure 14B). To evaluate
the protective effects of distinct Wnt ligands, I micro-injected Wnt8, Wnt 11 or
Wnt5a together with GSK3β and p120-catenin into Xenopus embryos, and then
monitored p120’s level by immunoblotting. Wnt8 as anticipated inhibited GSK3βfacilitated destruction of p120 (Figure 14B). Intriguingly, Wnt11 and Wnt5a showed
subtle protective effects upon p120 as well as β-catenin levels. Wnt8 is generally
thought to activate the canonical Wnt/ β-catenin pathway, while Wnt11 and Wnt5a
are portrayed as non-canonical in most contexts. However, Wnt11 and Wnt5a have
also been shown to activate the canonical pathway in axis formation in Xenopus
embryos (126, 127). Indeed, upon ectopical expression, p120 and even
endogenous β-catenin experienced a modest protective benefit when Wnt11 or
Wnt5a was co-expressed with GSK3β (Figure 11B). As anticipated, relative to Wnt8
and Wnt11, the non-canonical Wnt5a had lesser capacity to protect HA-p120 from
the effect of GSK3β (Figure 14B). Due to the complexity of reported Wnt ligand and
Frizzled receptor effects in Xenopus embryos during axis specification (etc.), I
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performed a knock-down approach in conjunction with a cell line system to evaluate
p120-catenin’s response to other Wnt signaling components such as Axin. MDAMB-231, HeLa and 293T cells were employed to examine the effect of knockingdown Axin 1&2 using proven siRNAs (20). Complimenting our over-expression
experiments conducted in Xenopus embryos, Axin1&2 depletion increased
endogenous p120-catenin’s stabilization in all tested cell lines, reflecting the role of
the destruction machinery in p120’s regulation (Figure 14D). Finally, I considered
existing models wherein canonical pathway activation leads to Dsh- and LRPmediated recruitment of Axin to the plasma membrane and degradation of Axin,
such that β-catenin escapes phosphorylation, ubiquitination and degradation. In
keeping with this model devised originally for β-catenin, I found that when Wnt8
expression levels increased, reduced amounts of p120 co-precipitated with Axin
(Figure 14E). Collectively, our data indicate that p120 and β-catenin are subject to
similar regulatory mechanisms in response to Wnt signals.
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Figure 14. Upstream Wnt pathway components modulate p120-catenin levels.
(A) Co-injection of Frodo or Wnt8 counter the effectiveness of Myc-GSK3β (5 pg) or
Myc-Axin (0.1 ng) to reduce HA-p120 (0.5 ng) levels. Embryos expressing up to two
exogenous constructs (as noted) in addition to HA-p120 were harvested at
gastrulation and corresponding lysates immunoblotted with anti-HA antibody to
detect p120. Actin was used as an internal loading control. Total mRNA injection
loads were equalized using β-galactosidase. (B) Exogenous Wnts (0.5 ng of Wnt8,
Wnt11 or Wnt5a mRNA) were co-injected with both HA-GSK3β (0.1ng) and HAp120 (0.25ng) into both blastomere of 2-cell embryos. At stage 12, Wnt protection
(versus not) from GSK3β impact upon HA-p120 was assessed by immunoblot. Actin
served as an internal loading control. (C) An increasing dose of Wnt8 mRNA was
co-injected with both HA-p120 (0.5ng) and Myc-Axin (0.5ng) into two blastomeres of
2-cell embryos that were later collected at gastrulation (stage 11, with 20 embryos
per condition). P120-catenin’s protein levels were assessed by immunoblotting. (D)
MDA-MB-231, HeLa and 293T cells were transfected with siRNAs directed against
Axin1&2 (50pmol), as indicated, for 48 hours. Endogenous p120-catenin levels
were monitored via anti-p120 immunoblotting (6H11). Each experiment was
repeated at least three times. (E) HA-p120 and Myc-Axin were co-injected into both
blastomeres of 2-cell stage embryos with the indicated amount of Wnt 8 ligand (0,
0.05 and 0.5ng). Gastrula stage embryos were harvested for immunoprecipitation/
immunoblotting. Myc-Axin immunoprecipitates were immunoblotted with anti-HA
antibody to detect the association of p120 with Axin. This figure was
modified/reproduced with from the permission Journal of Cell Science (119).
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The inhibition of upstream Wnt components reduces the level of p120-catenin
isoform-1

I further tested the effect of knocking down LRP5&6. Being positive modulators
of canonical Wnt signaling, I would expect that the knock down of LRP5&6 to
produce an impact opposite to Axin depletion. I employed a previously
characterized siRNA directed against LRP5&6 and confirmed its activity against
exogenous LRP5&6 (Figure 15A) (20), and indeed found that p120 levels were
diminished upon LRP5&6 depletion in MDA-MB-435 and HeLa cells (Figure
15B&C). Intriguingly, the pp120 antibody, which detects the C-terminal region of
p120, and thus detects most p120-catenin isoforms, revealed that the longer
isoform of p120-catenin, presumably p120-catenin isoform-1, was more responsive
to LRP5&6 depletion. Since isoform-2 and higher initiate translation at a primary
sequence position following p120’s destruction motif, this endogenous data appears
to support the view that p120’s most amino-terminal region, present in isoform-1, is
required for its regulation by the Wnt pathway. This view was additionally supported
via use of proteasome and CK1 inhibitors (D4476), which resulted in increased
p120 isoform-1 levels (Figure 6). Consistently, lesser effects on isoform-3 were
resolved upon proteasome (MG132) or CK1 inhibition (Figure 6A&6D). Although
p120 isoform-3 showed a lesser response to inhibition of the upstream Wnt pathway
or the destruction complex, it still exhibited some response to Wnt signaling in the
endogenous context. I thus assayed further possible for differences between p120
isoforms using exogenous constructs. I transfected full-length xp120 (similar to
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human isoform-1) or an N-terminal deletion mutant (ΔNp120; similar to human
isoform-4) into 293T cells. Based upon RNA expression, prior reports indicate
occurrence of two Xenopus p120 isoforms (iso1 similar to hp120 isoform-1; and
iso2 similar to hp120 isoform-3) upon RNA expression. However, the Xenopus iso2
(similar to hp120 isoform-3) is not yet functionally characterized, while Xenopus
isoforms similar to hp120 isoform-2 or -4 are not yet reported. As noted earlier,
ΔNp120 lacks the amino-terminal destruction box modulated by the Wnt pathway as
well as another potential GSK phosphorylation site (S199). ΔNp120 also associate
with neither GSK or CK1 (Figure 9B&D), nor evidence of ubiquitination (Figure 9C).
Thus, while human isoforms-3 and -4 are functionally distinct (84, 128), we largely
used ΔNp120 (Xenopus surrogate isoform-4) to compare Wnt pathway responses
with isoform-1. Relative to Xenopus isoform-1 (full-length), ΔNp120 did not respond
to CK1 or proteasome inhibition (Figure 15D). To complement our Xenopus
experiments, I compared mouse isoform-1 versus -3 upon GSK3 inhibition using
another agent, BIO (inhibition of GSK), in 293T cells. Isoform-1 became modestly
but reproducibly stabilized, whereas isoform-3 appeared unresponsive upon BIO
treatment (Figure 15E). Inhibition of CK1 reproducibly showed a modest response
by isoform-1, but not by isoform-3 (Figure 15E). Collectively, our data point to the
view that p120 and β-catenin, and likely additional p120 subfamily members, share
regulatory mechanisms responsive to Wnt signaling activity. Further, with respect to
p120, it is isoform-1 that is most clearly modulated, consistent with its capacity to
associate with destruction complex components and to be phosphorylated by
CK1/GSK3β.
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Figure 15. P120-catenin isoform-1 is most responsive to canonical Wnt
signals. (A) HeLa cells were transiently transfected with siRNA for LRP5 or LRP6
(50pmol), along with either Myc-tagged LRP5 or LRP6, and effects assessed via
Myc-immunoblot. (B) MDA-435 cells were seeded in 6-well plates followed by
transfection with LRP5&6 siRNAs. The effect of LRP5&6 depletion on p120-catenin
was monitored using distinct antibodies directed against p120 (pp120 or 6H11). The
asterisk indicates a non-specific band serving as an additional negative control. (C)
The stability of p120-catenin in HeLa cells was resolved as described for (B). (D)
Myc-p120 full-length (isoform-1) or ΔN-p120 were transiently transfected into 293T
cells for 24 hours, followed by MG132 or D4476 treatment (6 hours) at the indicated
doses. The levels of p120 were monitored via Myc-immunoblot. (E) 293T cells
were transiently transfected with mouse p120 isoform-1A or -3A. P120-catenin
isoforms were monitored in the presence of BIO or D4476 (6 hours), employing antiMyc antibody. This figure was modified/reproduced with permission from the
Journal of Cell Science (119).
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The amino-terminal portion of p120-catenin is critical for its functional activity

Given that ΔNp120 (similar to hp120 isoform-4) and mp120 isoform-3 appears
to be less responsive to the Wnt pathway (Figure 15D&E), I next questioned how
this isoform selectivity acts in whole Xenopus embryos. While we had previously
tested only Xenopus isoform-1 expression in Xenopus, there are at least two (likely
more) Xenopus isoforms (89). Since this second Xenopus isoform is not yet isolated
(equivalent to human isoform-3), we compared Xenopus p120-catenin isoform-1
with an xp120 amino-terminal deletion construct similar in structure to human p120
isoform-4 (ΔN-p120; removal of amino acids 1-341). ΔN-p120 lacks the aminoterminal destruction motif, so it was initially expected to be more stable and to
increase target-gene expression more robustly than Xenopus p120 isoform-1 (more
effective at relieving Kaiso-mediated repression of target genes). While it exhibited
higher protein expression levels as anticipated (Figure 16A), our preliminary results
indicate that ΔN-p120 does not produce gastrulation failures above negative-control
levels, and further, it exhibits less impact than p120 isoform-1 upon Siamois and
Wnt11 gene expression (Figure 16B&C). P120 has multiple roles that extend to the
modulation of RhoA and Rac (48-50), and as supported by recently published work
(84, 129), we were reminded that ΔN-p120 expression may have produced lesser
gastrulation phenotypes due to its reduced capacity to regulate small GTPases.
Further, ΔN-p120’s reduced activation of Wnt-11 expression (weaker relief of Kaisomediated repression of Wnt-11; functional underpinnings are unclear) would be
expected to result in lesser ectopic activation of PCP signaling (62). We speculate
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that under physiologic conditions, p120 isoform-1 plays more prominent roles in cell
and morphogenic (eg. gastrulation) movements than shorter isoforms.
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Figure 16. The amino-terminal region of p120-catenin isoform-1 contributes to
its functional developmental effects in Xenopus embryos. (A) mRNA encoding
β-galactosidase (2 ng) (negative control), Myc-p120 (2 ng) or Myc-ΔN-p120 mRNA
(0.5 ng) were injected into one-cell stage embryos, harvested at gastrula stage 10.5
and Myc immunoblotted. Actin serves as a loading/ negative control. (B)
Gastrulation failures, scored grossly at embryonic stage 12, following expression of
full-length versus DN-p120. The gray bar indicates the fraction of partial gastrulation
failure, while the black bar reflects complete gastrulation failure. (C) βgalactosidase (negative control) (2ng), Myc-p120 (2ng) or Myc-ΔN p120 (0.5 ng)
were injected into one-cell embryos. Gastrula-stage (91) cDNA was assayed by
real-time RT-PCR to assess the levels of xWnt-11 or xSiamois transcripts.
Unexpectedly, ΔN-p120 did not produce greater gastrulation failures relative to fulllength p120.
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Frodo has a selective impact upon p120-catenin

Our previous work showed that p120-catenin binds and is stabilized by the
intracellular protein Frodo, allowing the p120-catenin/ Kaiso pathway to modulate
certain Wnt target genes (70). We thus tested if Frodo depletion might also have an
impact upon β-catenin, but found that while p120 levels became lowered as
expected, β-catenin levels were maintained (Figure 17A). This was consistent with
our subsequent finding that Frodo does not appear to bind β-catenin, in contrast to
its known interaction with p120, suggesting that the selective role of Frodo in
regulating the canonical Wnt pathway may occur specifically through p120-catenin
(Figure 17B).
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Figure 17. Frodo associates with and stabilizes p120- but not β-catenin.
(A) Either HA-p120-catenin (0.25 ng) or Myc-β-catenin mRNA (0.25 ng) were coinjected with Frodo morpholino (10 ng, versus STD-MO/ negative control), into both
blastomeres of 2-cell embryos. Embryos were harvested at stage 11-12 for
immunoblotting with anti-Myc (β-catenin) or anti-HA antibody (p120). Actin serves
as a loading/ negative control. (B) Either Myc-β-catenin (0.5ng) or Myc-p120catenin (0.5ng) was co-injected with HA-Frodo (0.5ng) into both blastomere of
embryos at the 2-cell stage. Embryos were harvested at early-mid gastrula stages
(10-11) and lysates immuno-precipitated for HA-Frodo followed by Western blotting
to test for Myc-p120-catenin or Myc-β-catenin association (anti-HA antibody was
used to detect HA-Frodo). This figure was modified/reproduced with permission
from the Journal of Cell Science (119).
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Dapper, a close relative of Frodo, were previously reported to have an impact upon
p120-catenin’s stability (70). We thus tested whether Dapper has an impact upon
other p120 subfamily members. Strikingly, the depletion of Dapper in early Xenopus
embryos dramatically reduced the level of ectopically expressed δ-catenin and
Kaiso, as well as p120-catenin (positive control), suggesting its larger role in
modulating p120 subfamily biology (Figure 18). In summary, our results indicate that
components of the destruction complex known to act upon β-catenin are further
involved in regulating the level of p120 sub-family catenins, and that Frodo has a
more obvious impact upon the p120- than the β-catenin trajectory of the Wnt
pathway. I speculate that there may be additional currently unknown, but selective
modulators of the p120 subfamily, that allows for distinct catenin outputs (e.g. gene
regulation) in response to activation by different Wnt ligand on Wnt receptors.

77

Figure 18. Dapper appears to modulate p120-catenin subfamily members.
Either Myc-p120-catenin (0.25 ng), Myc-Kaiso or Myc-δ-catenin mRNA (0.25 ng)
were co-injected with Dapper morpholino (10 ng, versus STD-MO/ negative control),
into both blastomeres of 2-cell embryos. Embryos were harvested at stage 11-12 for
immunoblotting with anti-Myc (β-catenin) or anti-HA antibody (p120).
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Discussion

(Chapter III)

The canonical Wnt pathway has been viewed as having β-catenin as the primary
signal transduction mediator in response to Wnt pathway activation. While
plakoglobin/ γ-catenin, a member of the β-catenin sub-family, has been involved in
context-dependent Wnt gene regulation (58, 130), little emphasis has been directed
towards the possible roles of p120-catenin subfamily members.

P120 isoform-1 protein levels are subject to destruction complex regulation
Previous study from our group has pointed to the regulation of p120’s level in
response to the canonical Wnt signaling pathway via Frodo, resulting in the
modulation of certain Wnt/ β-catenin target genes harboring both Kaiso- and TCFbinding sites (61, 70). Based upon our prior findings, I hypothesized that additional
pathway components of the Wnt pathway might act upon p120-catenin, prompting
us to address potential mechanisms. In my first graduate work, I found that multiple
protein components involved with β-catenin’s destruction, also facilitate p120catenin degradation - with the prime examples being Axin and GSK3β. Employing
mapping studies with several deletion constructs, the amino-terminal region of
p120-catenin was determined to be responsible for rendering sensitivity to, and for
association with, destruction complex components (CK1α and GSK3β). Importantly,
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I found that the degradation mechanism applies mainly to p120 isoform-1, which
encompasses amino-terminal GSK3 and CK1 sites that are not present in isoforms
arising from more carboxyl-terminal translational initiations. I next mutated four
potential phospho-residues (Serine) predicted to harbor a CK1α/ GSK3β consensus
region and β-TrCP sites similar to that of β-catenin. In contrast to wild type, the
levels of this mutant construct when co-expressed with GSK3β were no longer
lowered. I further identified that the p120 point-mutant lost most of its capacity to
associate with β-TrCP and was largely free of ubiquitination. Expanding the
molecular mechanisms acting upon β-catenin’s stability to p120-catenin, I tested if
upstream components of the canonical Wnt pathway such as certain Wnt ligands
and LRP5&6, in addition to the little-understood component Frodo, produce
protective effects upon p120. While a core component of the destruction complex,
Axin, negatively modulates p120 in both Xenopus and cell line systems, the
upstream Wnt component, LRP5&6 protected p120 isoform-1 from degradation,
likely through recruiting the destruction complex to the plasma membrane to enable
its inactivation. My results point to the view that p120 protein levels are modulated
via mechanisms analogous to β-catenin in vivo. Interestingly, other members of
p120-catenin-subfamily, namely δ-catenin and ARVCF-catenin, were also
responsive (apparent substrates) of the destruction complex. While I did not
examine these latter catenins in depth, I note that in common with β-catenin and
p120, each contains a number of conserved potential GSK3β sites. Indeed,
independent evidence from the laboratory of K. Kim supports δ-catenin’s
responsiveness to GSK3β and ubiquitination (131). In their work, GSK3 depletion
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(via siRNA) or chemical inhibition increased δ-catenin’s levels. Consistent with my
findings centered upon p120, δ-catenin likewise became ubiquitinated in the
presence of MG132, with ubiquitination being reduced upon GSK inhibition.
Mutation of a potential GSK3 phosphorylation site (Thr1078 residue) resulted in less
ubiquitination, although interestingly, the site was located in δ-catenin’s carboxyl as
opposed to the amino-terminal region of p120-catenin. Together with our data here
and that earlier published (132), I envisage that the destruction complex of the
canonical Wnt pathway modulates multiple members of the catenin family, with
these catenins forming a Wnt responsive network extending considerably beyond βcatenin alone.

Intriguingly, an independent group recently reported p120-catenin’s involvement
in canonical Wnt signaling in a manner distinct from what we resolved (53). In their
report, p120 was found to promote Dishevelled phosphorylation through p120’s
interaction with CK1ε and E-cadherin in response to canonical Wnt ligand. This was
shown to increase β-catenin stability. This study complements our own, since
cadherin-dissociated p120 (perhaps more than one isoform) would represent a
distinct signaling-pool origin, whereas that which I describe arises from Wntpathway inhibition of the destruction complex, which exhibits selectivity towards
isoform-1. In all cases, my collective work supports the concept that p120-catenin
participates in canonical Wnt signaling (Figure 19).
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Figure 19. Model of the Wnt/p120/Kaiso signaling module in relation to Wnt
signaling activation. (A) In the absence of Wnt ligands, p120-catenin as well as βcatenin are degraded by the destruction complex via the proteasome-mediated
pathway. Thus, target genes are repressed more efficiently by TCF/LEF and Kaiso
transcriptional repressors. (B) In the presence of Wnt activation, Wnt ligands
associate with transmembrane proteins including LRP5/6 and Frizzled(s). Wnt
activation enables Dishevelled (Dsh) to recruit Axin and GSK3β to the plasma
membrane, which allows for β-catenin and p120-catenin stabilization. Stabilized βcatenin is more likely enter the nucleus to relieve repression conferred by TCF/LEF.
Concurrently, stabilized p120-catenin recruits Kaiso from the nucleus to the
cytoplasm by an unknown mechanism, presumably via p120’s entering the nucleus
to dissociate Kaiso from DNA. This results in de-repression of Kaiso target genes,
some of which are shared with TCF/LEF. This figure was adapted/modified from a
published paper, Park et al, Dev Cell, 2006 (70).
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Although our results indicate p120 (likely also ARVCF- and δ-catenin)
responsiveness to canonical Wnt pathway components/ signals, central questions
remain to be addressed. First is the issue of why, in addition to β-catenin, p120 and
other sub-family members would be coordinately regulated. In the case of p120catenin, evidence is accumulating to show that p120 acts in combination with βcatenin at shared and developmentally significant gene promoters, such as
Xenopus Siamois and to a lesser extent Wnt11. In the case of Siamois, for
example, gene activation occurs to an additively larger extent when β-catenin’s derepression of TCF/ LEF occurs in combination with p120-mediated de-repression of
the Kaiso transcriptional repressor (61, 62). Thus, the Wnt/ p120-catenin and Wnt/
β-catenin pathways could be required for coordinate regulation of Wnt signaling in
context dependent manners. Future study is required, especially as an independent
group has questioned if Siamois and Wnt11 are gene targets of Kaiso (63, 65),
Another independent study has supported the responsiveness of Siamois to Kaiso
depletion in the presence of weak Wnt pathway stimulation (64). Whatever the
outcome of this discussion, my data here while directed towards upstream p120
regulation, continue to be consistent with Siamois and Wnt11 gene responsiveness
to p120 and Kaiso (Figure 11). I thus expect that the Wnt/p120-catenin pathway,
and possibly the Wnt/ ARVCF and Wnt/ δ-catenin pathways, act in parallel with the
Wnt/β-catenin signaling trajectory to modulate certain canonical Wnt gene targets
(or cytoplasmic downstream effectors) in context dependent manners. Interestingly,
δ-catenin has also been reported to modulate Kaiso function at gene promoters
(133, 134), and ARVCF appears present in some cell/ tissue nuclei (135). While
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there is no prior report on the function of ARVCF in the nucleus, we have recently
resolved its interaction with Kazrin, a structurally novel and incompletely
characterized cortical/ junctional protein, which shuttles into the nucleus (136-138).
Collectively, a coordinate response of catenins could be imagined to lead a
networked gene regulatory readout downstream of Wnt signals. With respect to
potential upstream modulators of catenins, Frodo and the closely related Dapper,
which are known to functionally and physically interact with Dishevelled, will need to
be evaluated in the Wnt/p120 pathway context. Frodo and Dapper appear to
positively or negatively modulate Wnt signals in context-dependent manners (71,
72, 139, 140). In this study, I could not resolve a β-catenin:Frodo complex, although
I confirmed the expected interaction of p120-catenin:Frodo (70). Since Frodo binds
Dishevelled, we conjecture that Frodo exhibits some selectivity for the p120
signaling trajectory in upstream Wnt contexts, and that analogous but presently
undefined proteins may work together with Dishevelled to regulate the trajectory of
other catenins, especially p120-catenin subfamily members. Intriguingly, my data
presented here indicates that the depletion of Dapper diminished δ-catenin’s levels
in addition to p120. This suggests the possibility of Dapper being a more general
modulator of the Wnt pathway.

As noted earlier, the initial p120-catenin transcript (pre-RNA) is subject to interand intra-exonic splicing events that allow for the generation of multiple isoforms of
p120, as does the presence and use of four alternative translation start sites in
humans (87). Recent evidence indicates that differing isoforms confer distinct or
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even opposing functions, with regard to cell adhesion and invasion (84, 92, 141).
P120 isoform-1, transcribed from the first translational start site, includes the
destruction motif subject to Wnt-pathway regulation, and correspondingly is more
responsive to LRP5&6 depletion, or the inhibition of proteasomes, GSK3 or CK1. In
the context of exogenous p120 isoforms, isoform-1 was considerably more sensitive
than p120 isoform-3 or an N-terminal deletion mutant of p120, ΔNp120 (latter similar
to human isoform-4). Endogenous Xenopus isoforms equivalent to human isoform-2
and -4 have not yet been reported/ characterized. However, in certain mammalian
cell lines, I observed an additional response of isoform-3, which might conceivably
arise from its association with isoform-1, indirect effects upon the cadherin-catenin
complex, or the existence of additional destruction motifs within p120. Although
exogenous isoform-3 and ΔNp120 (similar to human isoform-4) produced similarly
absent or mild responses to the inhibition of GSK, CK1 or the proteasome, these
isoforms have distinctive features, including their most apparent intracellular
distributions (128). Relative of other p120 isoforms, expression of isoform-1 is
associated with cells having mesenchymal characteristics, and includes epithelial
cells that have undergone progression towards invasive and transformed cell states
(84). I thus envisage that regulatory events determining the choice of translational
initiation sites would provide another layer of control for p120’s responsiveness to
canonical Wnt signals. At present, little is known concerning how a particular
translational initiation site in the p120 transcript is selected, or similarly, what
governs the differential splicing decisions of the p120 transcript, which together
produce multiple p120 isoforms.
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Besides its nuclear functions, p120 sub-family members play additional key
roles at cell-cell junctions and other locations, modulating cadherin stability and
trafficking (120, 142, 143), as well as regulating small GTPases (eg. inhibiting RhoA
and activating Rac) (see Introduction). Thus, in considering the potential outcome of
Wnt signaling upon p120 sub-family members, we must include possible effects that
are not transcriptional in nature, but rather represent more immediate effects upon
cell adhesion, motility or cytoskeletal activity.
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Chapter IV

Signaling components having positive impact upon p120-catenin levels:
Down-syndrome related kinase Dyrk1A acts upon the p120/Kaiso trajectory of the
Wnt signaling pathway

89

Results

(Chapter IV)

Dyrk1A has an essential role in early embryonic development

To gain insight into the mechanisms by which p120-catenin is regulated, I
performed a small-scale kinase screen. Varied kinases were transfected into 293T
cells, and p120 levels monitored by immunoblotting (data not shown). Dyrk1A was
selected due to its robust impact on p120-catenin levels (see below). Although
mammalian Dyrk1A has been examined in embryonic development, Xenopus
Dyrk1A had yet to be evaluated. To address the molecular relationship of p120catenin with Dyrk1A, I designed a morpholino to deplete Dyrk1A in Xenopus
embryos. The characterization of the Dyrk1A morpholino is summarized in Figure
20. Employing an antibody directed against mouse, rabbit and human Dyrk1A,
endogenous Dyrk1A was detected in Xenopus embryo extracts. The level of Dyrk1A
was diminished in the presence of the Dyrk1A morpholino, suggesting specificity of
the Dyrk1A antibody and morpholino (Figure 20 A&B). Given that the mouse knockout of Dyrk1A is embryonic lethal (144), it was expected that Dyrk1A depletion
would result in severe defects during embryonic development. Indeed, Dyrk1A
depletion resulted in gastrulation failure at stage 12 in a significant fraction of
embryos (Figure 20C). Since Dyrk1A is a candidate gene for some of the
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neurobiological alterations observed in Down syndrome, I microinjected Dyrk1A
morpholino into the dorsal region of embryos at the 4-cell stage. Intriguingly, Dyrk1A
depletion in the dorsal-animal region resulted in embryos bearing kinks or shortened
axes (a and b), small heads (a and b), skin fragility (c and data not shown), and very
interestingly, developmental arrest (c) at neurulation stages (Stage 19-20) (Figure
21A). These phenotypes were reproducibly observed. Although the detailed
functions of Dyrk1A in early embryonic development requires further evaluation,
these data indicate that Dyrk1A has pivotal roles in amphibian development
consistent with knock-out or over-expression phenotypes defined in mouse, rat and
Drosophila.
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Figure 20. The characterization of Dyrk1A morpholino (A) Dyrk1A antisense
morpholino was designed to overlap the translational start site, and was
microinjected into 1-cell stage embryos. Endogenous Dyrk1A was detected with
polyclonoal Dyrk1A antibody (Abcam). Actin serves as a negative control. (B)
Increasing total doses of Dyrk1A morpholino were microinjected into Xenopus
embryos, and embryos harvested at late-gastrula stage 12. Endogenous p120catenin, β-catenin, C-cadherin and actin levels were respectively visualized via
immunoblotting. (C) Gross gastrulation effects following Dyrk1A depletion. In a
dose dependent manner, Dyrk1A depletion resulted in gastrulation failure. This data
reflects combined results from three independent experiments.
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Figure 21. Dyrk1A is essential to early embryonic development. (A) Dyrk1A
morpholino was microinjected at the indicated levels into each dorsal-animal
blastomere of 4-cell stage embryos. Embryos were monitored from stage 15-38 to
score for gross developmental defects. Data from two independent experiments are
represented in (B).
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Dyrk1A expression specifically increases p120-catenin protein levels

To validate Dyrk1A’s effects in vivo, in vitro transcribed mRNA encoding HAtagged xDyrk1A1 or 1A2 were co-injected with that for HA-p120 into Xenopus early
embryos. Co-expression of either Dyrk1A1 or 1A2 with p120 resulted in heightened
p120 protein levels (Figure 22A). This was in contrast to Dyrk1A Kinase Dead (KD),
which had no such effect (Figure 22B). Human Dyrk1A is encoded within the Down
Syndrome Critical (DSC) chromosomal region, which with increased gene copy
number contributes to human phenotypes including cognitive deficits (99, 145-147).
P120-catenin is likewise tied to brain cognitive functions, with gene knock-out
pointing to roles in dendritic spine and synapse formation (52, 148), and potentially,
morphogenetic events and plasticity of the CNS (107, 108). Consistent with our
Xenopus data, Dyrk1A transfected into 293T cells increased endogenous p120catenin levels, while β-catenin remained unaffected (Figure 22C). Likewise, we
determined that depletion of Dyrk1A, through the use of two independent Dyrk1A
siRNAs, strikingly lowered endogenous p120 but not β-catenin levels (Figure 22D).
Previous reports from our lab and others have shown that p120-catenin relieves
Kaiso-mediated repression of certain Wnt target genes such as Siamois and Wnt-11
(61, 62, 119). Upon binding, p120 is thought to somehow displace or compete Kaiso
from its sequence specific sites (KCS), and facilitate Kaiso’s departure from the
nucleus. We thus tested whether Dyrk1A expression likewise recruits Kaiso from
the nucleus. Consistent with a model where Dyrk1A stabilizes p120-catenin and is
positively involved in p120/Kaiso pathway function, exogenous Dyrk1A expression
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resulted in a significantly greater proportion of Kaiso appearing in the cytoplasm
(Figure 22E).
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Figure 22. Dyrk1A modulates p120-catenin levels and the intracellular
localization of Kaiso (A) Either Dyrk1A1 or 1A2 was co-injected with HA-tagged
p120-catenin (0.25 ng) into Xenopus embryos at the 1-cell stage, followed by
immunoblotting for HA-p120 or actin (negative control). (B) HA-p120 (0.25ng) was
microinjected into in 1-cell Xenopus embryos with wild-type or Kinase Dead (KD)
Dyrk1A. Embryos were harvested at early gastrula stages (10-11) and
immunoblotted for HA-p120, with actin serving as an internal loading control. (C)
Increasing doses of HA-tagged Dyrk1A were transfected into 293T cells, and
endogenous p120, β-catenin and GAPDH monitored via immunoblotting. (D) 293T
cells were transfected with one or both Dyrk1A siRNAs (50 pmol), as indicated, for
48 hours. Endogenous p120-catenin, β-catenin, Dyrk1A and GAPDH levels were
monitored via immunoblotting (pp120, BD Transduction; Dyrk1A, ab71464, Abcam).
The experiments were repeated three or more times. (E) HeLa cells were grown on
glass cover slips, and transiently transfected with Myc-Kaiso or Myc-Kaiso plus HADyrk1A as indicated. Cells were fixed with 4% PFA for 10 min, blocked with 5%
goat serum in PBS and immunostained with anti-Myc antibody.
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Association of Dyrk1A with p120-catenin

Given the effect of Dyrk1A on p120, we next examined whether Dyrk1A
interacts with p120-catenin. A Dyrk:p120 association was modestly but reproducibly
resolved (lane 6, Figure 23A), in contrast to C-Cadherin or β-catenin that did not coprecipitate (negative control lanes 2 & 10). Since p120-catenin belongs to the p120subfamily, other members such as ARVCF- and δ-catenin were examined.
Interestingly, only p120 associated with Dyrk1A (lane 3, Figure 23B), suggesting
that Dyrk1A might be a selective modulator of the p120/ Kaiso trajectory of the Wnt
pathway. To assess the interaction of endogenous Dyrk1A with endogenous p120,
we immunoprecipitated endogenous Dyrk1A from 293T-cell extracts, and resolved
p120 (lane 2, Figure 23C). Interestingly, an association of Dyrk1A with Kaiso,
presumably bridged through p120-catenin, was resolved when HA-Dyrk1A was
immunoprecipitated from Xenopus embryo extracts (lane 3, Figure 23D). To map
p120’s interaction region with Dyrk1A, we expressed p120 deletion constructs (a-f)
generated previously (119), and performed co-immunoprecipitations. Full-length (fl),
but more prominently the isolated amino-terminal region of p120 (c) associated with
Dyrk1A (lane 2, Figure 23E), while p120 constructs lacking this region (d&f), did not.
These results indicate that the Dyrk1A kinase is capable of associating with p120’s
N-terminal region, presumably accounting for Dyrk1A’s noted impact upon p120
protein levels (Figure 22).
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Figure 23. Association of Dyrk1A with p120-catenin
(A) Embryos were injected with HA-Dyrk1A and harvested at early gastrula (stage
10.5). Lysates were immunoprecipitated for HA-Dyrk1A, and the association with
endogenous p120-catenin resolved by immunoblotting. β-catenin and C-cadherin
served as negative controls. (B) HA-Dyrk1A (0.5ng) was co-injected with Myctagged β-catenin, C-cadherin, p120-catenin, ARVCF or δ-catenin (1ng) into both
blastomeres of 2-cell embryos. HA-Dyrk1A immunoprecipitates were immunoblotted
with anti-Myc antibody to detect co-associating proteins. (C) Endogenous Dyrk1A
was immunoprecipitated from 293T cells, and endogenous p120 monitored using
anti-p120 antibody (6H11). Asterisk indicates prospective Dyrk bands. (D) HADyrk1A was co-injected with Myc-p120 or Myc-Kaiso into early Xenopus embryos.
Embryos were harvested at gastrulation (stage 12), and lysates immunoprecipitated
for HA-Dyrk1A. Anti-Myc or -HA immunoblotting was used to test association of βcatenin, p120-catenin or Kaiso. (E) Depiction of Myc-p120-catenin deletion
constructs (a-f). Panels to the right show immunoblotting of the Myc-p120-catenin
constructs (a-f; 0.5 ng mRNA), co-precipitating (versus not) with co-injected HADyrk1A1 (0.5 ng mRNA).
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Acting through p120-catenin, Dyrk1A relieves Kaiso repressor activity

At the functional level, p120-catenin has a number of in vivo activities including
the capacity to relieve Kaiso-mediated repression of target genes containing
sequence-specific Kaiso consensus sites (KCS). Given that Dyrk1A associates with,
and by some mechanism results in increased p120 protein levels (we expect via
kinase-mediated stabilization, Figure 22B & see below), we tested if Dyrk1A
expression has an impact upon established endogenous p120/ Kaiso target genes
such as Wnt11 and Siamois. Indeed, as reflected via real-time PCR, the expression
of exogenous Dyrk1A in early Xenopus embryos (resulting in p120 stabilization and
thus relief of Kaiso-mediated repression) enhanced Wnt-11 and Siamois gene
transcription (Figure 24B). Complementing such over-expression data, the
morpholino-directed knock-down of Dyrk1A dramatically decreased both Wnt11 and
Siamois expression (Figure 24A). A previous report from our lab showed that the
Kaiso repressor is required for Xenopus gastrulation, with its depletion or overexpression resulting in respectively heightened or lowered expression of Wnt11,
and thus failed gastrulation movements (62). Based upon such findings, we tested if
Kaiso over-expression phenotypes could be rescued via co-expression of Dyrk1A.
As anticipated, exogenous Kaiso alone resulted in significant gastrulation-failure.
However, when Kaiso was co-expressed with a minimal amount of Dyrk1A
(previously titrated to exhibit little phenotypic consequence alone), significant
rescues were observed (Figure 24C&D). Consistent with such phenotypic rescues,
real-time PCR showed at the molecular level that exogenous Dyrk1A relieved gene
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repression due to exogenous Kaiso acting upon Wnt11 and Siamois (Figure 24E).
To further test the functional link between Dyrk1A and Kaiso (presumably taking
place via p120-catenin), we conversely made note of the fact that exogenous
Dyrk1A produces gastrulation delays in Xenopus embryos (data not shown). Thus,
we next tested if exogenous expression of Kaiso, the down-stream component,
could rescue Dyrk1A gastrulation delays. Although gastrulation delays produced by
Dyrk1A were subtle, I observed significant rescues with the appropriately titrated
expression of Kaiso (Figure 25A). Gene expression data upon Wnt11 and Siamois
likewise supported our model of the functional role of Dyrk1A on the p120/ Kaiso
pathway (Figure 25B). We next tested if p120 over-expression could interfere with
Kaiso’s rescue of Dyrk1 expression. Indeed, the co-injection of p120-catenin with
Kaiso and Dyrk1A re-elevated the level of gastrulation failures, as well as the level
of Wnt11 and Siamois (Figure 25C). These data suggest that Dyrk1A transmits an
apparently significant fraction of its biological activity through the p120/Kaiso
pathway.
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Figure 24. Dyrk1A modulates p120/ Kaiso-dependent gene expression
(A) The indicated amounts of Dyrk1A morpholino were injected into embryos at the
1-cell stage. Gastrula cDNA was assayed by real-time RT-PCR for Wnt11 and
Siamois transcript levels. Gene expression levels were normalized to ODC
(ornithine decarboxylase). (B) Dyrk1A (5pg) was injected into embryos at the 1-cell
stage. cDNA was isolated from gastrulation stage embryo lysates and analyzed by
real-time PCR for Wnt11 and Siamois transcript levels, normalized to ODC. (C&D)
Gastrulation (blastopore closure) failures followed the expression of Kaiso (0.5ng),
whereas the co-expression of Dyrk1A (5pg or 10pg), partially rescued Kaiso’s
effects. (E) Under similar experimental conditions, gastrula cDNA was assayed by
real-time RT-PCR for Wnt11 and Siamois transcript levels, normalized to ODC (right
panel).
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Figure 25. P120/Kaiso pathway rescues Dyrk1A-mediated effect in Xenopus
embryos (A) Kaiso expression rescues the gastrulation delays resulting from
Dyrk1A expression (left panels). (B) At the molecular level, Wnt11 and Siamois
transcript levels reflect the rescue effected by Kaiso. (C) Gastrulation failures
resulting from Dyrk1A expression are rescued by co-expression of Kaiso. The coexpression of a third component, p120-catenin, once again results in increased
gastrulation failures, presumably in part by relieving the repression/ rescue
conferred by Kaiso.
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xDyrk1A over-expression facilitates canonical Wnt signaling

Previously, our group determined that exogenous Kaiso represses canonical
Wnt signaling as evaluated using a classic in vivo assay, the suppression of ectopic
β-catenin-dependent axis duplication (61). Given that Dyrk1A stabilizes p120catenin, that in turn transcriptionally modulates a key gene product involved in axis
specification, Siamois, we tested if Dyrk1A has an impact upon β-catenin-mediated
axis duplication. By co-injecting mRNA encoding Dyrk1A and β-catenin into one cell
of 4-cell (as opposed to 1-cell) embryos (ventral-vegetal region), we largely avoided
gastrulation delays or failures resulting from Dyrk1A over-expression. As predicted,
co-expression of Dyrk1A with an intentionally modest (almost sub-phenotypic) dose
of β-catenin enhanced secondary axis formation in a dose-dependent manner
(Figure 26A). Kinase-dead Dyrk1A did not produce such effects (Dyrk1A KD,
negative control).
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Figure 26. Dyrk1A’s involvement in the canonical Wnt pathway (A) Duplicate
axis formation following the expression of a sub-maximal dose of β-catenin, is
enhanced upon the co-expression of the indicated doses of Dyrk1A, as evaluated in
tailbud embryos (stage 27-29). Kinase-dead (KD) Dyrk1A serves as a negative
control.
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Phospho-mimic mutant of p120 enhances target gene expression

As a first step in assessing the mechanism of Dryk1A’s effects, we searched for
potential Dyrk phosphorylation sites in p120. Consistent with our earlier
Dyrk1A:p120 association results (Figure 23), one evolutionary conserved Dyrk1A
phosphorylation site was resolved in the amino-terminal region of p120. This
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RVSP48 motif was comparable to the Dyrk canonical consensus (RPX(S/T)P; Fig.

27A), satisfying the requirement of proline-directed kinases for a proline
immediately trailing a serine/ threonine residue and the requirement of arginine for
substrate recognition (149). To approximate the impact of Dyrk1A phosphorylation
at this site, we generated a phospho-mimic point mutant (p120-T47D). P120-catenin
wild-type versus p120-T47D was expressed in Xenopus embryos (Fig. 27B). As
wild-type p120 over-expression relieves Kaiso-mediated gene repression and thus
contributes to failed gastrulation (p120 effects upon small-GTPases also contribute
to the observed phenotypes), we suspected that p120-T47D might be yet more
active in relieving Kaiso-mediated repression, possibly resulting from its increased
protein levels. As expected, p120-T47D proved more effective than wild-type in
promoting expression of the known p120/ Kaiso gene targets Siamois and Wnt11
(Fig. 27C). Correspondingly, p120-T47D produced greater levels of gastrulation
failure than corresponding doses of wild-type (Fig. 27D). The half-life of p120 wildtype (WT) versus the p120-T47D mutant was then tested in the presence of
cyclohexamide (CHX; Fig. 27E). As anticipated, p120-T47D exhibited a notably
prolonged half-life. To assess if threonine 47 of p120 is directly phosphorylated by
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Dyrk1A, we conducted an in vitro kinase assay using the amino-terminal region of
p120 versus the same region of p120-T47D. Phosphorylation by Dyrk1A of p120
was faint but reproducible, and did not appear upon p120-T47D, nor when kinasedead Dyrk1A was employed (Figure 28). These data together suggest that p120catenin phosphorylation by Dyrk1A is direct, and that such modification is relevant
to its functional role in embryonic development.
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Figure 27. Phosphorylation-dependent Dyrk1A in embryonic development
(A) Cross-species p120-catenin sequence alignment of the conserved predicted
Dyrk1A phosphorylation-site region (red box). (B) Expression of HA-p120 wild-type,
versus the phospho-mimic mutant (T47D), was detected via immuno-blotting of
Xenopus embryo lysates. (C) P120 wild-type (WT), or the p120 point-mutant
(T47D), were injected into Xenopus embryos at the 1-cell stage, followed later by
cDNA isolation and real-time PCR, to monitor increased Wnt11 and Siamois
transcript levels. (D) Gastrulation failures were more severe in embryos expressing
p120-T47D relative to p120-WT. (E) HA-p120 WT or T47D was expressed in HeLa
cells. Cells transfected with each construct were treated with cyclohexamide (CHX)
for the times indicated. Each HA-tagged construct was detected via immuno-blotting
of the corresponding cell extracts (right panel), followed by densitometer
quantitation of the band intensities (left panel). These data were collected from two
independent experiments.
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Figure 28. Dyrk1A phosphorylation of p120 in vitro. An amino-terminal region of
xp120-catenin (flag-tagged wild-type or T47D mutant; amino acids 1-280) (Hong et
al., J Cell Sci 2010), or full-length xDyrk1A (HA-tagged wild-type or kinase dead),
were each in vitro transcribed and translated using a reticulocyte lysates system
(Promega, L4611). Kinase (Dyrk1A) and substrate (xp120-catenin) were incubated
for 30 minutes at 30°C as indicated in kinase reaction buffer (10 mM Hepes, pH 7.5,
50 mM NaCl, 10 mM MgCl2, 10mM MnCl2, 1 mM EGTA, 1 mM dithiothreitol, 5 µM
ATP, 10 mM NaF and 1 mM Na3VO4), along with 10 µCi γ-32P-ATP. Samples were
then immunoprecipitated for 1 hour at 4°C with anti-FLAG-M2 magnetic beads
(Sigma) in the presence of 0.5% NP-40 Buffer (25mM HEPES pH 7.5, 150mM KCl,
0.5% NP-40, 1.5mM MgCl2, 10% glycerol, 5mM β-mercaptoethanol). The
precipitates were washed 3x and the samples then subjected to SDS-PAGE/
autoradiography. Anti-HA antibody (3F10) and anti-flag antibody (M2) were
employed to detect Dyrk1A and p120-catenin, respectively.
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Discussion

(Chapter IV)

In summary, I report here that the Down-syndrome related kinase, Dyrk1A,
associates with p120-catenin. This results in kinase-dependent increases in p120
levels, which in turn has an impact upon certain Wnt/ p120/ Kaiso target genes such
as Wnt11 and Siamois. I show that exogenous Kaiso expression rescues the effect
of Dyrk1A on target genes, suggesting that Dyrk1A transmits signals through the
p120/ Kaiso trajectory of the Wnt signaling pathway. The data presented here
provides new thoughts regarding Dyrk1A in development and perhaps disease.

Dyrk1A in the canonical Wnt signaling pathway

Although Dyrk1A is recognized as a critical component of Down syndrome
pathology, molecular analysis of Dyrk1A is at an early stage. There is accumulating
evidence regarding the substrates of Dyrk1A, for example, including caspase-9,
ASF (Alternative splicing factor), Tau, HPV16E7 and p53 (104, 150-154).
Substrates have shown variable responses, in some instances being destabilized in
conjunction with GSK3β activity, while in others showing increased or unchanged
levels. Until now, to our knowledge, there has been no prior reports indicating a
functional relationship linking Dyrk1A with the Wnt/ p120/ Kaiso pathway. Likewise,
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knowledge gaps exist concerning upstream signals relevant to Dyrk1A activity.
Intriguingly, a previous report from our lab identified Frodo as an upstream bindingmate and modulator of p120-catenin, but not of β-catenin (70, 119). The depletion of
Frodo decreases p120’s levels, seemingly similar to the depletion effect of Dyrk1A.
Thus, in the context of addressing p120 levels, and thereby the p120/ Kaiso
signaling trajectory, Frodo and Dyrk1A might functionally interact. Based upon these
interactions between Frodo, Dyrk1A and p120, one conceivable model is that Frodo
acts as a scaffold to recruit Dyrk1A and p120, resulting in p120’s increased level.
Some of such accumulated 120 might then enter the nucleus to assist in recruiting
Kaiso back to the cytoplasm, thereby de-repressing/ activating certain Wnt target
genes such as Siamois and Wnt11 by (Figure 29A). Dyrk1A mainly localizes in the
nucleus, while p120-catenin localizes largely to the cytoplasm. Thus, another
potential model is that Frodo might promote p120’s shuttling into the nucleus to be
phosphorylated by Dyrk1A, with the resulting increased level of p120 re-localizing
Kaiso from the nucleus to the cytoplasm (Figure 29B). Further study will increase
our knowledge of the p120/Kaiso trajectory of the canonical Wnt signaling pathway.
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Figure 29. Potential models of Dyrk1A/ p120/ Kaiso signaling in the context of
the Wnt pathway. (A) The first model hypothesizes that Frodo acts as a scaffolding
protein. In the presence of Wnt ligand, Frodo is activated by unknown mechanisms
and recruits p120 and Dyrk1A to enable their close association and the
phosphorylation of p120. Phosphorylated/ stabilized p120 enters the nucleus and
assists in trans-locating the Kaiso repressor from the nucleus to the cytoplasm,
resulting in gene activation. (B) Given that Dyrk1A mainly localizes to the nucleus,
p120-catenin might interact with Dyrk1A in the nucleus, as a result of p120 entry in
complex with Frodo. P120-catenin would then become phosphorylated by nuclear
Dyrk1A, bind Kaiso and shuttle with Kaiso to the cytoplasm to result in gene target
de-repression.
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Recently, in Xenopus, another member of the DYRK family of protein kinases,
Hipk2 was found to promote Wnt signaling via phosphorylation and relief of TCF3
repression of ventral target gene (155). Hipk2 has also been implicated in
phosphorylation of β-catenin (156). It is possible that canonical Wnt signals reside
upstream of Dyrk1A within the (Frodo)/ p120/ Kaiso trajectory, just as we and others
recently revealed is the case for p120, and likely for ARVCF- and δ-catenin (60, 61,
70, 119, 157, 158). Dyrk1A is a dual specificity protein kinase, which autophosphorylates on tyrosine residues, and phosphorylates other substrates on
serine/threonine residues. The activation loop is characterized by a conserved YXY
sequence whose tyrosine residues have been found phosphorylated in vivo (159).
Upstream or regulatory signaling components such as phosphatases have not yet
been identified. Given that Dyrk modulates certain downstream Wnt target genes
through the p120/Kaiso trajectory, upstream Wnt components might be involved in
Dyrk1A auto-phosphorylaton/activation . Future studies will be needed to define
upstream components of the Dyrk/p120/Kaiso pathway, possibly including Wnt
ligands.

Likewise as noted, it also remains to be determined whether Dyrk1A, through
p120, regulates small GTPases such as RhoA and Rac, perhaps thereby regulating
spine and synapse formation in the developing brain. Given that Dyrk1A dosage
imbalance is correlated with Down Syndrome, study of Dyrk1A-mediated effects
upon p120-catenin, and thereby upon nuclear Wnt-target genes and cytoplasmic
small-GTPases, warrants further examination in brain development. Understanding
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such functional interactions may assist in addressing Dyrk1A’s contributions to
Down syndrome, possibly for example, via effects upon p120-catenin and thus Wnt
signaling in CNS development.
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Chapter V

Significance and Future Directions

P120-catenin was originally identified as a preferred Src substrate (160). A
number of studies have focused upon p120’s phosphorylation within its aminoterminal regulatory domain (77). Since p120 becomes phosphorylated in
mammalian cell lines and its phosphorylation is relevant to its binding to cadherin
and thus cadherin stability, the identification of kinases that modulate p120catenin’s function or levels have been sought.

In this regard, my principal advancements were made in three areas. First, I
reveal two different molecular mechanisms wherein p120 stability is regulated.
These mechanisms are mediated through phosphorylation conferred by
GSK3β, CK1α or Dyrk1A. Second, I provide evidence that additional members of
the p120-catenin sub-family, ARVCF-catenin and δ-catenin, are further subjected to
modulation by the destruction complex. Third, I found that p120 isoform-1 among
multiple isoforms is more responsive to the Wnt pathway. Thus, in the future, p120
isoforms will require careful examination in both developmental and tumorigenesis
contexts. To achieve a better understanding of the p120 / Kaiso pathway in the
context of canonical Wnt signals, further studies are required as discussed here.
124

[Molecular mechanisms regulating p120-catenin]

The broad impact of Wnt signaling on other catenin family members

As mentioned earlier, other p120 subfamily members such as ARVCF-catenin
and δ-catenin were found to associate with Axin, a scaffolding component of the
destruction machinery. The protein levels of these additional p120 subfamily
members were likewise responsive to the presence of destruction complex
components. Based upon findings illustrated in Chapter III, it may be beneficial to
identify conserved destruction motifs within further p120 subfamily members, which
presumably become phosphorylated by GKS3β or other kinases to initiate
degradation. Based upon alignment data and in silico analysis employing programs
to predict phosphorylation sites, (NetPhospho and GPS2.1), I have found that
ARVCF, δ-catenin and plakophilin have conserved sequences predicted to be
phosphorylated by GSK3β and CK1α (Figure 30). One potential GSK
phosphorylation region, that in turn contains a predicted β-TrCP binding site, was
identified in the C-terminal end of human, mouse, Xenopus, Zebrafish and cow
plakophilin-3. Interestingly, two serines in this region were mutated to alanines in
Xenopus and Zebrafish, leaving open the possibility of differences in the plakophilin3 Wnt response of mammals and amphibians. Another conserved potential GSK
sites were found in the amino-terminal region of pkp-3, but without an integrated βTrCP binding site. Each potential GSK3β, CK1α phosphorylation site in ARVCFand δ-catenin is illustrated in Figure 30. Future study of the molecular mechanisms
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regulating p120 subfamily members will contribute to our larger understanding of
the canonical Wnt pathway, as will the identification of downstream gene targets of
ARVCF-catenin, δ-catenin or the plakophilins (desmosomal catenins).
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Figure 30. Cross-species sequence alignment of the region of p120-catenin
subfamily members harboring conserved predicted GSK3β phosphorylation
and β-TrCP binding sites. In plakophilin-3, the red box includes conserved
potential GSK3β sites, and a DSEXXS motif consistent with the possibility of being
a β-TrCP binding site.
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What selective signaling entities act upon particular p120-catenin subfamily
members?

During my graduate study, I found that upstream Wnt components modulate the
p120/Kaiso pathway by inhibiting the destruction complex in a manner similar to that
used in regulating β-catenin. In our group’s earlier report, we showed that Frodo
stabilizes p120, thereby assisting in the transmission of Wnt/ p120/ Kaiso signals to
downstream target genes upon Wnt stimulation. My findings here suggest that
Frodo acts upon p120-catenin, but not (or less so) upon β-catenin. For example,
immuno-precipitations from Xenopus embryo extracts revealed the existence of a
Frodo:p120 complex, while a Frodo:β-catenin complex was not resolved.
Furthermore, Frodo depletion only diminished p120’s levels, whereas β-catenin
levels remained steady, suggesting a selective role of Frodo downstream of
canonical Wnt signals. It is thus conceivable that there exist other currently
unknown proteins that confer a form of selectivity for facilitating canonical Wnt
signals to particular p120-catenin family members. If more such molecules are
identified, another layer of complexity of canonical Wnt signaling will be revealed.
For example, in my hands, Dapper, which is structurally similar to Frodo, appears to
have a protective impact upon δ-catenin as well as p120-catenin (Figure 18). This
suggests that Dapper might modulate catenins in response to Wnt signals as does
Frodo. Since Dishevelled is a focal point in the transmission of both canonical- and
non-canonical-Wnt signals, the context dependent modulation of β-catenin versus
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p120 subfamily members may further involve “choices” made at the level of
Dishevelled.

As mentioned earlier, a number of Wnt ligands and Frizzled receptors exist (19
& 13 in mammals, respectively). Different combination of Wnt:Frizzled complexes
have distinct roles in development. For example, xWnt5a is often characterized as a
non-canonical Wnt ligand. However, in the presence of hFz5, Wnt5a can induce an
ectopic Spemann organizer and axis duplication in Xenopus embryos, well
established properties reflecting canonical activity (161). Upon the association of
Wnt ligand with the Frizzled receptor, Dishevelled becomes localized to the plasma
membrane, associating with Frizzled. Given that Frodo binds Dishevelled and
apparently assists in transmitting canonical Wnt signals to the p120/ Kaiso trajectory,
I envisage that different Wnt:Frizzled combinations may recruit distinct modulators
(Frodo, Dapper or others), with these modulators selecting one or another catenin
family member in a context dependent manner. Over-expression or knock-down of
Wnt ligand or Frizzled receptor components could be employed to test if we can
identify differential effects upon the level of β-catenin, p120-catenin or other p120
subfamily members. Once endogenous gene targets of the differing catenins
become known, they may also serve as reporters for the activity of differing Wnt
ligand:receptor combinations, to again address the hypothetical differential effects
upon distinct p120 subfamily members.
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With regards to the second part of my graduate work focused upon Dyrk1A,
recent reports by others show that the kinases Hipk1 and Hipk2 contribute to Wnt
signaling in certain embryonic context, either positively or negatively affecting βcatenin levels (156, 162, 163). For example, in early ventral tissue of Xenopus, it
was shown that Hipk2 is recruited by a β-catenin-mediated mechanism to the TCF
complex, leading to TCF phosphorylation and dissociation from target gene
promoters (155). Interestingly, although I did not observe p120 levels altered upon
Hipk2 expression in mammalian cells, Hipk2 was also identified in yeast two-hybrid
screening as a binding partner of the p120 modulator Frodo (personal
communication from Dr. Sergei Y. Sokol). Dyrk family members include Dyrk1, 2, 3,
and Hipk1, 2. Interestingly, our group previously reported that Frodo depletion
diminished p120 levels, as I have observed upon Dyrk1A depletion. Thus, it is
conceivable that Dyrk1A might act upon p120’s level through phosphorylation of
Frodo or an association with Frodo. Upon study of Frodo’s primary sequence
(GPS2.1 software), I resolved multiple potential Dyrk1A phosphorylation sites. Thus,
I envisage that Dyrk1A either phosphorylates p120-catenin or Frodo, and that
phosphorylation recruits Frodo to the Dyrk1A / p120 complex, stabilizing p120catenin. Intriguingly, one of the predicted Dyrk phosphorylation sites in Frodo is
conserved in Dapper, suggesting this could be a critical site for both proteins.
Another possibility is that Frodo serves as a scaffold to recruit Dyrk1A to p120catenin. Being similar in structure to Frodo, Dapper is another candidate that may
participate in the Dyrk/ p120 pathway. Since Frodo associates with Dishevelled,
acts upon the p120/ Kaiso pathway and modulates small GTPases, it is germane to
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examine the potential role of Dyrk1A in these same processes. These data may
provide the research community with new insights on the molecular mechanisms of
Dyrk1A and its role in development or pathologies including Down syndrome.

Does Dyrk1A modulate Cadherin or small GTPases through p120?

Intriguingly, I found that ventral expression of p120-catenin with Dyrk1A results
in skin fragility in Xenopus embryos (Figure 25). Embryos at stage 26 displayed
impaired skin integrity potentially due to an effect upon cadherin-mediated adhesion
and/ or upon small GTPases such as RhoA and Rac. Microinjection of either p120
or Dyrk1A alone did not confer these phenotypes. Based upon p120’s positive role
in the stabilization of cadherin and its modulation of small GTPases, I envisage that
Dyrk1A acts through p120 to regulate either cadherin stability and/ or small
GTPases. Dissociation/ association tests using cells derived from Xenopus embryo
animal caps will be employed to test if Dyrk1A has an impact upon p120’s
regulation of small GTPases and cadherin. In mammalian cells, exogenous p120 is
known to induce branching phenotypes via the modulation of small GTPases.
Interestingly, Dryk1A expression in 293T cells results in a branching morphology
similar to that seen following expression of p120-catenin. Thus, Dyrk1A depletion or
over-expression will be employed to test Dyrk1A’s involvement in modulating small
GTPases through the elevation of p120 levels. This study may additionally provide
some information regarding how the Dyrk/ p120 pathway conceivably contributes to
Down syndrome pathology.
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Figure 31. Skin fragility results from co-injection of Dyrk1A with p120
(A) Myc-p120-catenin was co-injected with either β-gal or Dyrk1A into the ventralvegetal region of 4-cell stage embryos. Skin defects were observed at stage 26,
when the images were taken.
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[ P120-catenin in cancer and development ]

P120-catenin isoforms in development and cancer

P120-catenin has multiple isoforms and its expression and localization varies
depending on tissues and cell types. The ablation of p120-catenin in mouse
intestine, skin, salivary gland and enamel resulted in severe developmental defects
(51, 164-167). Interestingly, p120 isoform-1 is present during rat brain development,
with its expression decreasing in adult brain. P120 isoform-1 is rich in the cortex,
cerebellum, the olfactory bulb and the hippocampus (107). The spatial-temporal
expression of p120-catenin isoforms in most tissues is not yet defined. Thus, the
expression pattern of p120-catenin isoforms having distinct functions need to be
evaluated. Furthermore, to investigate the roles of distinct p120 isoforms during
development, rescue of p120 knock-down in Xenopus embryos would seem a
reasonable approach.

P120 misexpression is associated with multiple cancer types and poor
prognosis of several cancer. P120 variables include its total level of expression,
intracellular localization and the relative ratios of its expressed isoforms. For
example, p120 isoform-1 over-expression is evident in several lung cancers and
breast cancer, correlating with poor prognosis and lymph node metastasis, poor
differentiation, histological type and high TNM stage (92, 168). In stark contrast to
metastatic lymph nodes wherein p120 isoform-1’s level is high, in normal lung, p120
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isoform-1 expression is very low. Additionally, cytoplasmic Kaiso co-localization with
p120 was discovered in metastatic lung cancer lesions, fitting with p120’s known
capacity to displace Kaiso from gene promoters and sequester it in the cytoplasm
(hence relieving Kaiso-mediated gene repression, resulting in the transcription of
multiple downstream genes, most of which are unknown) (91). Although it is unclear
which p120 isoform(s) is primarily responsible for Kaiso relocalization in cancer, I
hypothesize that p120-catenin, especially isoform-1 is a contributing modulator of
Wnt signaling (and possibly also small GTPases) in cancer metastasis. One recent
study in breast cancer showed that a long p120 isoform (presumably isoform-1) was
present in the nucleus of invasive ductal and lobular carcinomas. Together with
studies in lung cancer, I envisage that the canonical Wnt pathway may relay signals
through p120 isoform-1 that are relevant to cancer metastasis. Although
considerable work has been committed to the role of p120-catenin in cancer, there
remain mixed ideas of how the varying isoforms regulate tumor progression (87,
169-172). P120-catenin’s role in cancer has primarily been studied with regard to Ecadherin stability, and to a lesser extent, small GTPase activity. P120-catenin was
known to stabilize cadherin, inhibit Rho and activate Rac. Our recently published
work together with that of others points to a new possibility, wherein the relationship
between the Wnt pathway and p120 nuclear functions needs future evaluation.

Future study includes generating an antibody against active (unphosphorylated
destruction box) p120 isoform-1, to detect the presence of stabilized p120 isoform-1
in cancer tissues, especially in lung and breast cancer tissues given that p120
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isoform-1 is highly expressed in this pathologic context. Using this antibody, the
expression levels and intracellular localization of active p120 isoform-1 will be
assessed, together with that of additional Wnt pathway components using
immunohistochemistry. To begin to address the role of p120 isoform-1 in cancer
metastasis where it is present at elevated levels, cancer cell lines will be selectively
depleted with siRNA for p120 isoform-1. Then, assays relevant to aggressive cell
characteristics will be undertaken, such as measures of cell motility and invasion.
These experiments will provide valuable information on p120 isoform-1 from the
perspective of Wnt signaling and gene target activation.

Dyrk/ p120/ Kaiso in neural development

In rat brain development, p120-catenin is distributed at the plasma membrane
(cell:cell junctions) and within the cytoplasm, suggesting a possible role of p120 in
neural development. P120 is co-localized with a subset of synapses in cultured
hippocampus neurons (107). In mouse forebrain, the depletion of p120-catenin
reduced spine and synapse densities (52). Additionally, ectopically expressed p120
resulted in a branching phenotype in mammalian cell lines, roughly resembling
neurite outgrowths (173). Interestingly, my preliminary evidence indicates that
Dyrk1A promotes p120’s branching phenotype (data not shown). Given that the
branching phenotype was employed as an assay to uncover p120’s relationship to
small-GTPases in prior studies by others, this assay can also be applied to study of
p120’s roles in neuronal development. Appearing consistent with such p120
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involvement, the p120 binding partner Kaiso, a POZ / zinc finger transcriptional
repressor, is expressed strongly in brain, eye, spinal cord, and brancial arches
during Xenopus embryonic development. It is thus conceivable that the
Dyrk1A/p120/Kaiso pathway might participate neuronal development and
differentiation. Because Dyrk1A is likely to be associated with Down syndrome, the
study of this pathway in neuronal function and differentiation may provide valuable
information on our larger understanding of Down syndrome and p120-catenin in
brain development.

Understanding the molecular mechanisms of Dyrk1A is at early stage. There are
several Dyrk1A substrates identified such as p53 and tau, and from my work, p120catenin. However, there are no prior findings relating to upstream regulators of
Dyrk1A. As alluded to above, Dyrk1A appears to participate in modulation of the
Wnt/ p120-catenin pathway in development, and is thus perhaps itself regulated by
more upstream events in Wnt signaling, such as those immediately following Wntligand: receptor interactions. Future study will include testing upstream candidates
that may impinge on Dyrk1A/ p120 pathway activity.
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